US20220015367A1 - Self-assembled active agents - Google Patents
Self-assembled active agents Download PDFInfo
- Publication number
- US20220015367A1 US20220015367A1 US17/469,773 US202117469773A US2022015367A1 US 20220015367 A1 US20220015367 A1 US 20220015367A1 US 202117469773 A US202117469773 A US 202117469773A US 2022015367 A1 US2022015367 A1 US 2022015367A1
- Authority
- US
- United States
- Prior art keywords
- component
- active agent
- molecule
- self
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013543 active substance Substances 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 claims abstract description 63
- 150000001412 amines Chemical class 0.000 claims abstract description 27
- 230000008569 process Effects 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 60
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 47
- 150000001299 aldehydes Chemical class 0.000 claims description 42
- 125000001931 aliphatic group Chemical group 0.000 claims description 34
- 230000000845 anti-microbial effect Effects 0.000 claims description 30
- 150000002148 esters Chemical class 0.000 claims description 22
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 19
- 150000002576 ketones Chemical class 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 19
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 150000007970 thio esters Chemical class 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 230000002147 killing effect Effects 0.000 claims description 17
- 238000001338 self-assembly Methods 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 15
- 150000007513 acids Chemical class 0.000 claims description 15
- 150000002170 ethers Chemical class 0.000 claims description 15
- 125000000524 functional group Chemical group 0.000 claims description 15
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- 150000003573 thiols Chemical class 0.000 claims description 15
- 150000001298 alcohols Chemical class 0.000 claims description 11
- IZALUMVGBVKPJD-UHFFFAOYSA-N benzene-1,3-dicarbaldehyde Chemical compound O=CC1=CC=CC(C=O)=C1 IZALUMVGBVKPJD-UHFFFAOYSA-N 0.000 claims description 11
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- JGGFDEJXWLAQKR-UHFFFAOYSA-N 1,2-diaminoguanidine Chemical group NNC(N)=NN JGGFDEJXWLAQKR-UHFFFAOYSA-N 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 10
- 125000005842 heteroatom Chemical group 0.000 claims description 10
- 125000000623 heterocyclic group Chemical group 0.000 claims description 10
- 150000007857 hydrazones Chemical class 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 244000052769 pathogen Species 0.000 claims description 10
- 230000001717 pathogenic effect Effects 0.000 claims description 10
- PXJJKVNIMAZHCB-UHFFFAOYSA-N 2,5-diformylfuran Chemical compound O=CC1=CC=C(C=O)O1 PXJJKVNIMAZHCB-UHFFFAOYSA-N 0.000 claims description 9
- RZUSSKMZLHKMHU-UHFFFAOYSA-N 2-bromobenzene-1,3-dicarbaldehyde Chemical compound BrC1=C(C=O)C=CC=C1C=O RZUSSKMZLHKMHU-UHFFFAOYSA-N 0.000 claims description 9
- OTMRXENQDSQACG-UHFFFAOYSA-N thiophene-2,5-dicarbaldehyde Chemical compound O=CC1=CC=C(C=O)S1 OTMRXENQDSQACG-UHFFFAOYSA-N 0.000 claims description 9
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 7
- AEKQNAANFVOBCU-UHFFFAOYSA-N benzene-1,3,5-tricarbaldehyde Chemical compound O=CC1=CC(C=O)=CC(C=O)=C1 AEKQNAANFVOBCU-UHFFFAOYSA-N 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 claims description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- 229940015043 glyoxal Drugs 0.000 claims description 5
- 150000004820 halides Chemical class 0.000 claims description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 5
- OSVFOHHYFMQYRN-UHFFFAOYSA-N (3,5-diformyl-2-propoxyphenyl)boronic acid Chemical compound CCCOC1=C(C=O)C=C(C=O)C=C1B(O)O OSVFOHHYFMQYRN-UHFFFAOYSA-N 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003172 aldehyde group Chemical group 0.000 claims description 3
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 239000004599 antimicrobial Substances 0.000 abstract description 29
- 230000002441 reversible effect Effects 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003755 preservative agent Substances 0.000 abstract description 8
- 239000003139 biocide Substances 0.000 abstract description 6
- 230000003115 biocidal effect Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 239000000645 desinfectant Substances 0.000 abstract description 5
- 230000002335 preservative effect Effects 0.000 abstract description 3
- 239000002519 antifouling agent Substances 0.000 abstract description 2
- 239000003443 antiviral agent Substances 0.000 abstract description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- WTWBUQJHJGUZCY-UHFFFAOYSA-N cuminaldehyde Chemical compound CC(C)C1=CC=C(C=O)C=C1 WTWBUQJHJGUZCY-UHFFFAOYSA-N 0.000 description 32
- 0 C=[3*]=NNC(=C)NN=C.[1*]=NNC(=C)N.[1*]=NNC(=C)NN=[1*].[NH4+].[NH4+].[NH4+] Chemical compound C=[3*]=NNC(=C)NN=C.[1*]=NNC(=C)N.[1*]=NNC(=C)NN=[1*].[NH4+].[NH4+].[NH4+] 0.000 description 16
- -1 antiseptics Substances 0.000 description 16
- FQQQSNAVVZSYMB-UHFFFAOYSA-N 1,1-diaminoguanidine Chemical compound NN(N)C(N)=N FQQQSNAVVZSYMB-UHFFFAOYSA-N 0.000 description 10
- 230000036515 potency Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 9
- 231100000252 nontoxic Toxicity 0.000 description 9
- 230000003000 nontoxic effect Effects 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 7
- LWRSYTXEQUUTKW-UHFFFAOYSA-N 2,4-dimethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(OC)=C1 LWRSYTXEQUUTKW-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IXWOUPGDGMCKGT-UHFFFAOYSA-N 2,3-dihydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1O IXWOUPGDGMCKGT-UHFFFAOYSA-N 0.000 description 4
- JIVGSHFYXPRRSZ-UHFFFAOYSA-N 2,3-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OC JIVGSHFYXPRRSZ-UHFFFAOYSA-N 0.000 description 4
- CRBZVDLXAIFERF-UHFFFAOYSA-N 2,4,6-trimethoxybenzaldehyde Chemical compound COC1=CC(OC)=C(C=O)C(OC)=C1 CRBZVDLXAIFERF-UHFFFAOYSA-N 0.000 description 4
- CLFRCXCBWIQVRN-UHFFFAOYSA-N 2,5-dihydroxybenzaldehyde Chemical compound OC1=CC=C(O)C(C=O)=C1 CLFRCXCBWIQVRN-UHFFFAOYSA-N 0.000 description 4
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 description 4
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 4
- 240000000940 Araucaria angustifolia Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 4
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 3
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- 244000166124 Eucalyptus globulus Species 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006664 bond formation reaction Methods 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- UCTUXUGXIFRVGX-UHFFFAOYSA-N 2,3,4-trimethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(OC)=C1OC UCTUXUGXIFRVGX-UHFFFAOYSA-N 0.000 description 2
- BTQAJGSMXCDDAJ-UHFFFAOYSA-N 2,4,6-trihydroxybenzaldehyde Chemical compound OC1=CC(O)=C(C=O)C(O)=C1 BTQAJGSMXCDDAJ-UHFFFAOYSA-N 0.000 description 2
- IUNJCFABHJZSKB-UHFFFAOYSA-N 2,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C(O)=C1 IUNJCFABHJZSKB-UHFFFAOYSA-N 0.000 description 2
- AFUKNJHPZAVHGQ-UHFFFAOYSA-N 2,5-dimethoxy-Benzaldehyde Chemical compound COC1=CC=C(OC)C(C=O)=C1 AFUKNJHPZAVHGQ-UHFFFAOYSA-N 0.000 description 2
- WXSGQHKHUYTJNB-UHFFFAOYSA-N 2,6-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(OC)=C1C=O WXSGQHKHUYTJNB-UHFFFAOYSA-N 0.000 description 2
- DUVJMSPTZMCSTQ-UHFFFAOYSA-N 2-ethoxybenzaldehyde Chemical compound CCOC1=CC=CC=C1C=O DUVJMSPTZMCSTQ-UHFFFAOYSA-N 0.000 description 2
- OPHQOIGEOHXOGX-UHFFFAOYSA-N 3,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1OC OPHQOIGEOHXOGX-UHFFFAOYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- VFZRZRDOXPRTSC-UHFFFAOYSA-N 3,5-Dimethoxybenzaldehyde Chemical compound COC1=CC(OC)=CC(C=O)=C1 VFZRZRDOXPRTSC-UHFFFAOYSA-N 0.000 description 2
- LXPWGAZYJHUWPM-UHFFFAOYSA-N 4-(2-methylpropyl)benzaldehyde Chemical compound CC(C)CC1=CC=C(C=O)C=C1 LXPWGAZYJHUWPM-UHFFFAOYSA-N 0.000 description 2
- IHKVZPVHTKOSLW-UHFFFAOYSA-N 4-octylbenzaldehyde Chemical compound CCCCCCCCC1=CC=C(C=O)C=C1 IHKVZPVHTKOSLW-UHFFFAOYSA-N 0.000 description 2
- 241001331781 Aspergillus brasiliensis Species 0.000 description 2
- BCNNGMWXXGIFFM-UHFFFAOYSA-O CC(C)CC1=CC=C(C=NCC(N)=[NH2+])C=C1 Chemical compound CC(C)CC1=CC=C(C=NCC(N)=[NH2+])C=C1 BCNNGMWXXGIFFM-UHFFFAOYSA-O 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 240000004784 Cymbopogon citratus Species 0.000 description 2
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241000366676 Justicia pectoralis Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000000078 anti-malarial effect Effects 0.000 description 2
- 230000000884 anti-protozoa Effects 0.000 description 2
- 239000003430 antimalarial agent Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000006652 catabolic pathway Effects 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000010773 plant oil Substances 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000000654 trypanocidal effect Effects 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- PZSJOBKRSVRODF-UHFFFAOYSA-N vanillin acetate Chemical compound COC1=CC(C=O)=CC=C1OC(C)=O PZSJOBKRSVRODF-UHFFFAOYSA-N 0.000 description 2
- ORUDEUCNYHCHPB-OUUBHVDSSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-tetradecoxyoxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ORUDEUCNYHCHPB-OUUBHVDSSA-N 0.000 description 1
- MOOFYEJFXBSZGE-QJUDHZBZSA-N 1,2-bis[(z)-(4-chlorophenyl)methylideneamino]guanidine Chemical compound C=1C=C(Cl)C=CC=1\C=N/N=C(/N)N\N=C/C1=CC=C(Cl)C=C1 MOOFYEJFXBSZGE-QJUDHZBZSA-N 0.000 description 1
- IAJBQAYHSQIQRE-UHFFFAOYSA-N 2,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(OC)=C(C=O)C=C1OC IAJBQAYHSQIQRE-UHFFFAOYSA-N 0.000 description 1
- QOJQBWSZHCKOLL-UHFFFAOYSA-N 2,6-dimethylbenzaldehyde Chemical compound CC1=CC=CC(C)=C1C=O QOJQBWSZHCKOLL-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- WZUODJNEIXSNEU-UHFFFAOYSA-N 2-Hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(O)=C1 WZUODJNEIXSNEU-UHFFFAOYSA-N 0.000 description 1
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- FQRQWPNYJOFDLO-UHFFFAOYSA-N 2-hydroxy-4,6-dimethoxybenzaldehyde Chemical compound COC1=CC(O)=C(C=O)C(OC)=C1 FQRQWPNYJOFDLO-UHFFFAOYSA-N 0.000 description 1
- RGZHEOWNTDJLAQ-UHFFFAOYSA-N 3,4,5-trihydroxybenzaldehyde Chemical compound OC1=CC(C=O)=CC(O)=C1O RGZHEOWNTDJLAQ-UHFFFAOYSA-N 0.000 description 1
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 1
- RRKMWVISRMWBAL-UHFFFAOYSA-N 3,4-dihydroxy-5-methoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(O)=C1O RRKMWVISRMWBAL-UHFFFAOYSA-N 0.000 description 1
- HAQLHRYUDBKTJG-UHFFFAOYSA-N 3,5-dihydroxybenzaldehyde Chemical compound OC1=CC(O)=CC(C=O)=C1 HAQLHRYUDBKTJG-UHFFFAOYSA-N 0.000 description 1
- ARIREUPIXAKDAY-UHFFFAOYSA-N 4-butylbenzaldehyde Chemical compound CCCCC1=CC=C(C=O)C=C1 ARIREUPIXAKDAY-UHFFFAOYSA-N 0.000 description 1
- JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 description 1
- HZWPJAZIRZFCGX-UHFFFAOYSA-N 4-hydroxy-2,6-dimethoxybenzaldehyde Chemical compound COC1=CC(O)=CC(OC)=C1C=O HZWPJAZIRZFCGX-UHFFFAOYSA-N 0.000 description 1
- OTXINXDGSUFPNU-UHFFFAOYSA-N 4-tert-butylbenzaldehyde Chemical compound CC(C)(C)C1=CC=C(C=O)C=C1 OTXINXDGSUFPNU-UHFFFAOYSA-N 0.000 description 1
- QYYMDNHUJFIDDQ-UHFFFAOYSA-N 5-chloro-2-methyl-1,2-thiazol-3-one;2-methyl-1,2-thiazol-3-one Chemical compound CN1SC=CC1=O.CN1SC(Cl)=CC1=O QYYMDNHUJFIDDQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- HDFAJBUCAFTCTJ-UHFFFAOYSA-O C.CC(=[NH2+])NN.O Chemical compound C.CC(=[NH2+])NN.O HDFAJBUCAFTCTJ-UHFFFAOYSA-O 0.000 description 1
- BVHFUKTWDLQSTK-UHFFFAOYSA-A C=C(C)C1CC=C(C=NNC(N)=[NH2+])CC1.CC(C)(C)C1=CC(C=NNC(N)=[NH2+])=C(O)C(C=NNC(N)=[NH2+])=C1.CC(C)=CCCC(C)=CC=NCC(N)=[NH2+].CC(C)=CCCC(C)CC=NCC(N)=[NH2+].CC1=CC(C=NNC(N)=[NH2+])=C(O)C(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(Br)=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=NNC(N)=[NH2+])=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC(C=NNC(N)=[NH2+])=C1 Chemical compound C=C(C)C1CC=C(C=NNC(N)=[NH2+])CC1.CC(C)(C)C1=CC(C=NNC(N)=[NH2+])=C(O)C(C=NNC(N)=[NH2+])=C1.CC(C)=CCCC(C)=CC=NCC(N)=[NH2+].CC(C)=CCCC(C)CC=NCC(N)=[NH2+].CC1=CC(C=NNC(N)=[NH2+])=C(O)C(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(Br)=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=NNC(N)=[NH2+])=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC(C=NNC(N)=[NH2+])=C1 BVHFUKTWDLQSTK-UHFFFAOYSA-A 0.000 description 1
- NFVDFKWFOMATDX-UHFFFAOYSA-U C=CC1=C(OCCC)C(B(O)O)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC(B(O)O)=C(OCCC)C(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)C=C1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)O1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)S1.C=CC=NNC(=[NH2+])NN=C.C=CCCCC=NNC(=[NH2+])NN=C Chemical compound C=CC1=C(OCCC)C(B(O)O)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC(B(O)O)=C(OCCC)C(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)C=C1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)O1.C=CC1=CC=C(C=NNC(=[NH2+])NN=C)S1.C=CC=NNC(=[NH2+])NN=C.C=CCCCC=NNC(=[NH2+])NN=C NFVDFKWFOMATDX-UHFFFAOYSA-U 0.000 description 1
- XGPNLXCKGKJKGM-UHFFFAOYSA-U C=CC1=CC(Br)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC(C)=CC(C=NNC(=[NH2+])NN=C)=C1O.C=CC1=CC(C=C)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC=CC(C=NNC(=[NH2+])NN=C)=C1.C=CNC(=[NH2+])NN=CC1=C(O)C(C=C)=CC(C(C)(C)C)=C1.CC(C)(C)C1=CC(C=O)=C(O)C(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)O1 Chemical compound C=CC1=CC(Br)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC(C)=CC(C=NNC(=[NH2+])NN=C)=C1O.C=CC1=CC(C=C)=CC(C=NNC(=[NH2+])NN=C)=C1.C=CC1=CC=CC(C=NNC(=[NH2+])NN=C)=C1.C=CNC(=[NH2+])NN=CC1=C(O)C(C=C)=CC(C(C)(C)C)=C1.CC(C)(C)C1=CC(C=O)=C(O)C(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)O1 XGPNLXCKGKJKGM-UHFFFAOYSA-U 0.000 description 1
- WQNTWZJPCLUXQC-UHFFFAOYSA-N CC(C)(C)C1=CC(C=O)=C(O)C(C=O)=C1 Chemical compound CC(C)(C)C1=CC(C=O)=C(O)C(C=O)=C1 WQNTWZJPCLUXQC-UHFFFAOYSA-N 0.000 description 1
- KESVOWPMBQZQIZ-NDLLPDMASA-U CC(C)(C)C1=CC=C(/C=N/CC(N)=[NH2+])C=C1.CC(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=C(C=NCC(N)=[NH2+])C=CC=C1.CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=CC=CC(C=NCC(=N)N)=C1.CCCCC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(/C=N/CC(N)=[NH2+])C=CC=C1.NC(=[NH2+])CN=CC1=CC=CC=C1 Chemical compound CC(C)(C)C1=CC=C(/C=N/CC(N)=[NH2+])C=C1.CC(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=C(C=NCC(N)=[NH2+])C=CC=C1.CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=CC=CC(C=NCC(=N)N)=C1.CCCCC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(/C=N/CC(N)=[NH2+])C=CC=C1.NC(=[NH2+])CN=CC1=CC=CC=C1 KESVOWPMBQZQIZ-NDLLPDMASA-U 0.000 description 1
- NFOKIGUXLKTGGE-UHFFFAOYSA-U CC(C)(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC(C)CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCCCC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCCCCCCCC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCOC1=CC=CC=C1C=NCC(N)=[NH2+].NC(=[NH2+])CN=CC1=CC=CC=C1 Chemical compound CC(C)(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC(C)C1=CC=C(C=NCC(N)=[NH2+])C=C1.CC(C)CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCCCC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCCCCCCCC1=CC=C(C=NCC(N)=[NH2+])C=C1.CCOC1=CC=CC=C1C=NCC(N)=[NH2+].NC(=[NH2+])CN=CC1=CC=CC=C1 NFOKIGUXLKTGGE-UHFFFAOYSA-U 0.000 description 1
- FXULVNVXFQWQHB-YQQAFNMCSA-O CC(C)=CCC/C(C)=C/C=N/CC(N)=[NH2+] Chemical compound CC(C)=CCC/C(C)=C/C=N/CC(N)=[NH2+] FXULVNVXFQWQHB-YQQAFNMCSA-O 0.000 description 1
- JRIVJLICMLRXDR-VDGGBKBOSA-R CC(C)=CCC/C(C)=C/C=N/CC(N)=[NH2+].CCC1=C(O)C=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(C)C=CC(/C=N/CC(N)=[NH2+])=C1.COC1=CC=CC=C1/C=N/CC(N)=[NH2+] Chemical compound CC(C)=CCC/C(C)=C/C=N/CC(N)=[NH2+].CCC1=C(O)C=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(C)C=CC(/C=N/CC(N)=[NH2+])=C1.COC1=CC=CC=C1/C=N/CC(N)=[NH2+] JRIVJLICMLRXDR-VDGGBKBOSA-R 0.000 description 1
- SLFAEZBDOVHCFL-VRWOOBJSSA-S CC1=C(O)C=C(C=NCC(=N)N)C=C1.CC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.CCOC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(C)C(O)=CC(/C=N/CC(N)=[NH2+])=C1.COC1=C(OC)C=C(C=NCC(=N)N)C=C1.COC1=CC(/C=N/CC(N)=[NH2+])=CC(OC)=C1O.COC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=CC=CC(C=NCC(=N)N)=C1 Chemical compound CC1=C(O)C=C(C=NCC(=N)N)C=C1.CC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.CCOC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=C(C)C(O)=CC(/C=N/CC(N)=[NH2+])=C1.COC1=C(OC)C=C(C=NCC(=N)N)C=C1.COC1=CC(/C=N/CC(N)=[NH2+])=CC(OC)=C1O.COC1=CC=C(/C=N/CC(N)=[NH2+])C=C1.COC1=CC=CC(C=NCC(=N)N)=C1 SLFAEZBDOVHCFL-VRWOOBJSSA-S 0.000 description 1
- UQGSWXDBYGACFT-UHFFFAOYSA-V CC1=CC(C=NCC(N)=[NH2+])=CC=C1.CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=CC=CC(C)=C1C=NCC(N)=[NH2+].CC1=CC=CC=C1C=NCC(N)=[NH2+].COC1=CC(C=NCC(N)=[NH2+])=CC=C1.COC1=CC=C(C=NCC(N)=[NH2+])C=C1OC.NC(=[NH2+])CN=CC1=CC=C(O)C(O)=C1.NC(=[NH2+])CN=CC1=CC=CN=C1 Chemical compound CC1=CC(C=NCC(N)=[NH2+])=CC=C1.CC1=CC=C(C=NCC(N)=[NH2+])C=C1.CC1=CC=CC(C)=C1C=NCC(N)=[NH2+].CC1=CC=CC=C1C=NCC(N)=[NH2+].COC1=CC(C=NCC(N)=[NH2+])=CC=C1.COC1=CC=C(C=NCC(N)=[NH2+])C=C1OC.NC(=[NH2+])CN=CC1=CC=C(O)C(O)=C1.NC(=[NH2+])CN=CC1=CC=CN=C1 UQGSWXDBYGACFT-UHFFFAOYSA-V 0.000 description 1
- BUWGNMPKWSQXHT-UHFFFAOYSA-W CC1=CC(C=O)=C(O)C(C=NNC(N)=[NH2+])=C1.CCCOC1=C(B(O)O)C=C(C=NNC(N)=[NH2+])C=C1C=O.CCCOC1=C(B(O)O)C=C(C=O)C=C1C=NNC(N)=[NH2+].NC(=[NH2+])NN=CC1=CC(Br)=CC(C=O)=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)C=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)S1.NC(=[NH2+])NN=CC=O.NC(=[NH2+])NN=CCCCC=O Chemical compound CC1=CC(C=O)=C(O)C(C=NNC(N)=[NH2+])=C1.CCCOC1=C(B(O)O)C=C(C=NNC(N)=[NH2+])C=C1C=O.CCCOC1=C(B(O)O)C=C(C=O)C=C1C=NNC(N)=[NH2+].NC(=[NH2+])NN=CC1=CC(Br)=CC(C=O)=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)C=C1.NC(=[NH2+])NN=CC1=CC=C(C=O)S1.NC(=[NH2+])NN=CC=O.NC(=[NH2+])NN=CCCCC=O BUWGNMPKWSQXHT-UHFFFAOYSA-W 0.000 description 1
- ZBOUXALQDLLARY-UHFFFAOYSA-N CC1=CC(C=O)=C(O)C(C=O)=C1 Chemical compound CC1=CC(C=O)=C(O)C(C=O)=C1 ZBOUXALQDLLARY-UHFFFAOYSA-N 0.000 description 1
- FKPYTGFJEBPPCE-AWNIVKPZSA-O CC1=CC=C(/C=N/CC(N)=[NH2+])C=C1 Chemical compound CC1=CC=C(/C=N/CC(N)=[NH2+])C=C1 FKPYTGFJEBPPCE-AWNIVKPZSA-O 0.000 description 1
- RXHRYVBLZLGGNC-UHFFFAOYSA-N CC1=CC=C(C)O1.CC1=CC=C(C)S1.[KH] Chemical compound CC1=CC=C(C)O1.CC1=CC=C(C)S1.[KH] RXHRYVBLZLGGNC-UHFFFAOYSA-N 0.000 description 1
- KMCXEYBDLUKIMU-UHFFFAOYSA-Z CCCOC1=C(B(O)O)C=C(C=NNC(N)=[NH2+])C=C1C=NNC(=N)N.N=C(N)NN=CC1=CC(C=NNC(N)=[NH2+])=CC=C1.N=C(N)NN=CC1=CC=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC(C=O)=C1.NC(=[NH2+])NN=CC1=CC=C(C=NNC(N)=[NH2+])O1.NC(=[NH2+])NN=CC1=CC=C(C=NNC(N)=[NH2+])S1.NC(=[NH2+])NN=CC=NNC(N)=[NH2+].NC(=[NH2+])NN=CCCCC=NNC(N)=[NH2+] Chemical compound CCCOC1=C(B(O)O)C=C(C=NNC(N)=[NH2+])C=C1C=NNC(=N)N.N=C(N)NN=CC1=CC(C=NNC(N)=[NH2+])=CC=C1.N=C(N)NN=CC1=CC=CC(C=NNC(N)=[NH2+])=C1.NC(=[NH2+])NN=CC1=CC(C=O)=CC(C=O)=C1.NC(=[NH2+])NN=CC1=CC=C(C=NNC(N)=[NH2+])O1.NC(=[NH2+])NN=CC1=CC=C(C=NNC(N)=[NH2+])S1.NC(=[NH2+])NN=CC=NNC(N)=[NH2+].NC(=[NH2+])NN=CCCCC=NNC(N)=[NH2+] KMCXEYBDLUKIMU-UHFFFAOYSA-Z 0.000 description 1
- KRNIUWLFMBNATK-UHFFFAOYSA-U CCOC1=CC=C(C=NCC(N)=[NH2+])C=C1.COC1=C(O)C(O)=CC(C=NCC(N)=[NH2+])=C1.COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1O.COC1=CC=C(C=NCC(N)=[NH2+])C(O)=C1.NC(=[NH2+])CN=CC1=CC(O)=C(O)C(O)=C1.NC(=[NH2+])CN=CC1=CC=CC(O)=C1.NC(=[NH2+])CN=CC1=CC=CC(O)=C1O Chemical compound CCOC1=CC=C(C=NCC(N)=[NH2+])C=C1.COC1=C(O)C(O)=CC(C=NCC(N)=[NH2+])=C1.COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1O.COC1=CC=C(C=NCC(N)=[NH2+])C(O)=C1.NC(=[NH2+])CN=CC1=CC(O)=C(O)C(O)=C1.NC(=[NH2+])CN=CC1=CC=CC(O)=C1.NC(=[NH2+])CN=CC1=CC=CC(O)=C1O KRNIUWLFMBNATK-UHFFFAOYSA-U 0.000 description 1
- FWMIUUPSGSWSNW-LHHJGKSTSA-O COC1=C(C)C(O)=CC(/C=N/CC(N)=[NH2+])=C1 Chemical compound COC1=C(C)C(O)=CC(/C=N/CC(N)=[NH2+])=C1 FWMIUUPSGSWSNW-LHHJGKSTSA-O 0.000 description 1
- GGHCUIPZXFKYKN-UHFFFAOYSA-U COC1=C(O)C(C=NCC(N)=[NH2+])=CC=C1.COC1=C(O)C=C(C=NCC(N)=[NH2+])C=C1.COC1=C(O)C=CC(C=NCC(N)=[NH2+])=C1.COC1=C(OC(=O)C(C)C)C=CC(C=NCC(N)=[NH2+])=C1.COC1=C(OC(C)=O)C=CC(C=NCC(N)=[NH2+])=C1.COC1=CC=C(C=NCC(N)=[NH2+])C=C1.COC1=CC=CC=C1C=NCC(N)=[NH2+] Chemical compound COC1=C(O)C(C=NCC(N)=[NH2+])=CC=C1.COC1=C(O)C=C(C=NCC(N)=[NH2+])C=C1.COC1=C(O)C=CC(C=NCC(N)=[NH2+])=C1.COC1=C(OC(=O)C(C)C)C=CC(C=NCC(N)=[NH2+])=C1.COC1=C(OC(C)=O)C=CC(C=NCC(N)=[NH2+])=C1.COC1=CC=C(C=NCC(N)=[NH2+])C=C1.COC1=CC=CC=C1C=NCC(N)=[NH2+] GGHCUIPZXFKYKN-UHFFFAOYSA-U 0.000 description 1
- HQHKMRZCULNPKS-UHFFFAOYSA-V COC1=C(OC)C(C=NCC(N)=[NH2+])=CC=C1.COC1=CC(C=CC=NCC(N)=[NH2+])=CC=C1O.COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1.COC1=CC(OC)=C(C=NCC(N)=[NH2+])C(OC)=C1.COC1=CC=C(C=NCC(N)=[NH2+])C(OC)=C1OC.NC(=[NH2+])CN=CC1=CC(O)=CC(O)=C1.NC(=[NH2+])CN=CC1=CC=C(O)C=C1.NC(=[NH2+])CN=CC1=CC=C(O)C=C1O Chemical compound COC1=C(OC)C(C=NCC(N)=[NH2+])=CC=C1.COC1=CC(C=CC=NCC(N)=[NH2+])=CC=C1O.COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1.COC1=CC(OC)=C(C=NCC(N)=[NH2+])C(OC)=C1.COC1=CC=C(C=NCC(N)=[NH2+])C(OC)=C1OC.NC(=[NH2+])CN=CC1=CC(O)=CC(O)=C1.NC(=[NH2+])CN=CC1=CC=C(O)C=C1.NC(=[NH2+])CN=CC1=CC=C(O)C=C1O HQHKMRZCULNPKS-UHFFFAOYSA-V 0.000 description 1
- QWMXLKWEMVGWFB-UHFFFAOYSA-U COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1OC.COC1=CC(OC)=C(OC)C=C1C=NCC(N)=[NH2+].COC1=CC=C(C=NCC(N)=[NH2+])C(OC)=C1.COC1=CC=C(OC)C(C=NCC(N)=[NH2+])=C1.COC1=CC=CC(OC)=C1C=NCC(N)=[NH2+].NC(=[NH2+])CN=CC1=C(O)C=C(O)C=C1O.NC(=[NH2+])CN=CC1=CC(O)=CC=C1O Chemical compound COC1=CC(C=NCC(N)=[NH2+])=CC(OC)=C1OC.COC1=CC(OC)=C(OC)C=C1C=NCC(N)=[NH2+].COC1=CC=C(C=NCC(N)=[NH2+])C(OC)=C1.COC1=CC=C(OC)C(C=NCC(N)=[NH2+])=C1.COC1=CC=CC(OC)=C1C=NCC(N)=[NH2+].NC(=[NH2+])CN=CC1=C(O)C=C(O)C=C1O.NC(=[NH2+])CN=CC1=CC(O)=CC=C1O QWMXLKWEMVGWFB-UHFFFAOYSA-U 0.000 description 1
- DBBVKGPSOPVIRZ-AWNIVKPZSA-O COC1=CC=CC=C1/C=N/CC(N)=[NH2+] Chemical compound COC1=CC=CC=C1/C=N/CC(N)=[NH2+] DBBVKGPSOPVIRZ-AWNIVKPZSA-O 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 206010011906 Death Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical group SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000001242 French lavender Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000192710 Microcystis aeruginosa Species 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ALZRLMMYVBSOIU-UHFFFAOYSA-N O=CC1=CC=C(C(C)C)C=C1.NNC(=N)N Chemical compound O=CC1=CC=C(C(C)C)C=C1.NNC(=N)N ALZRLMMYVBSOIU-UHFFFAOYSA-N 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- BGKAKRUFBSTALK-UHFFFAOYSA-N Vanillin isobutyrate Chemical compound COC1=CC(C=O)=CC=C1OC(=O)C(C)C BGKAKRUFBSTALK-UHFFFAOYSA-N 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003214 anti-biofilm Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- DNAVOCNYHNNEQI-UHFFFAOYSA-N asaronaldehyde Natural products COC1=CC(OC)=C(C=CC=O)C=C1OC DNAVOCNYHNNEQI-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- DKZBBWMURDFHNE-UHFFFAOYSA-N coniferyl aldehyde Chemical compound COC1=CC(C=CC=O)=CC=C1O DKZBBWMURDFHNE-UHFFFAOYSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 125000005597 hydrazone group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000001964 liazer and helhal Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 238000003415 nucleophilic catalysis Methods 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 description 1
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical class O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960004591 robenidine Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000001966 spaanse laventel Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N49/00—Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean —Y— or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/08—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing boron
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Definitions
- Chemical antimicrobial agents such as antibiotics, antiseptics, disinfectants and preservatives are essential for modern medicine, agriculture and other industries. Despite this importance, chemical antimicrobial agents often exhibit significant toxicity to non-microbial organisms, thereby causing collateral damage to ecosystems and also accelerating the evolution of antimicrobial resistance. The latter two problems may result from a substance's persistence in the environment. The longer a substance persists in the environment, the greater the potential for bioaccumulation and microbial exposure at sub-inhibitory concentrations, the latter of which enables the evolution of antimicrobial resistance. This effect is cause for concern; some estimates predict mortalities from antibiotic resistant infections may surpass those from cancer within several decades. Given the growing hazard of antimicrobial resistance and the damage to the environment caused by persistent chemicals, the development of antimicrobials that are short-lived in the environment is needed.
- Hydrazone bond formation has been widely used to construct thermodynamically stable, yet kinetically reversible, covalent molecular complexes that are stable in aqueous solution near neutral pH (Dirksen, et al., Nucleophilic Catalysis of Hydrazone Formation and Transimination: Implications for Dynamic Covalent Chemistry, J. Am. Chem. Soc., 128: 15602-15603 (2006); Rodriguez-Docampo, Z., and S. Otto, Orthogonal or Simultaneous Use of Disulfide and Hydrazone Exchange in Dynamic Covalent Chemistry in Aqueous Solution, Chem. Commun., pages 5301-5303 (2008)).
- Bond formation and dissociation is dynamic and rapid, often occurring within seconds to minutes at room temperature (King, T. P., et al., Preparation of Protein Conjugates via Intermolecular Hydrazone Linkage, Biochemistry (Mosc.), 25: 5774-5779 (1986); Dirksen, A., and P. E. Dawson, Rapid Oxime and Hydrazone Ligations with Aromatic Aldehydes for Biomolecular Labeling, Bioconjug. Chem., 19: 2543-2548 (2008); and Nguyen, R., and I. Huc, Optimizing the Reversibility of Hydrazone Formation for Dynamic Combinatorial Chemistry, Chem. Commun., pages 942-943 (2003)).
- Custalcean and coworkers employed hydrazone bond formation to construct a class of self-assembled cations that associate strongly with anions (Custelcean, R., et al., Aqueous Sulfate Separation by Crystallization of Sulfate-Water Clusters, Angew. Chem. Int.
- a composition may include a compound of the formula:
- R 1 and R 3 are, independently, one of a straight chain or branched, saturated or unsaturated aliphatic group, a 5-member ring, or a 6-member ring
- R 1 and R 3 are, independently, optionally substituted one or more times, in the case of either of R 1 or R 3 being a 6-member ring, the 6-member ring is optionally an aromatic ring
- a first substitution is one of an alcohol group, an aldehyde group, a 5-member ring, a 6-member ring, a halide, a halide-diol, an ether, and a straight or branched, saturated or unsaturated aliphatic group.
- the compound may be one of the compounds disclosed in FIG. 5A , FIG. 5B , FIG. 5C and FIG. 5D .
- a composition may include a compound of the formula:
- R 1 and R 2 independently represent: (1) hydrogen (—H), or (2) an aliphatic (saturated or unsaturated, straight chain or branched) functional group (e.g., C 1-10 alkyl) that may be substituted with additional aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C 1 to C 10 ), phenolic, —OH groups, ethers (e.g. —OMe, —OEt, where the alkyl portion of the ester ranges from C 1 to C 10 ), esters (e.g. —CO 2 Me, —CO 2 Et, where the alkyl portion of the ester ranges from C 1 to C 10 ), acids (e.g.
- boronic —BO 2 , or carboxylic, —CO 2 H
- amines and ammoniums e.g. —NR 3 R 4 or —(NR 3 R 4 R 5 ) +
- alcohols e.g. —CH 2 OH where the alkyl portion of the alcohol ranges from C 1 to C 10
- thiol and thioesters e.g. —SH, —SMe, —SEt, where the alkyl portion of the thioester ranges from C 1 to C 10
- halogens e.g.
- an aromatic functional group e.g., C 6 H 5 or derivatives wherein one or more —H is substituted with an alkyl (e.g., C 1-10 ), with aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C 1 to C 10 ), phenolic, —OH groups, ethers (e.g. —OMe, —OEt, where the alkyl portion of the ester ranges from C 1 to C 10 ), esters (e.g.
- R 3 , R 4 and R 5 independently represent a hydrogen of aliphatic (saturated or unsaturated, straight chain or branched, e.g., C 1-10 alkyl) functional group that may be substituted, for example, with additional aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C 1 to C 10 ), —OH groups, ethers (e.g.
- esters e.g. —CO 2 Me, —CO 2 Et, where the alkyl portion of the ester ranges from C 1 to C 10
- acids e.g. boronic, —BO 2 , or carboxylic, —CO 2 H
- amines and ammoniums alcohols e.g. —CH 2 OH where the alkyl portion of the alcohol ranges from C 1 to C 10
- thiol and thioesters e.g. —SH, —SMe, —SEt, where the alkyl portion of the thioester ranges from C 1 to C 10
- halogens e.g. —Cl, —Br
- the compound may be an active agent.
- the active agent may be formed by self-assembly of a first component molecule and a second component molecule.
- the active agent may have antimicrobial activity.
- a method for treating a pathogen or microbe may include applying an effective amount of an active agent to a designated area or object, the active agent being the compound described above.
- the active agent may be one of the compounds disclosed in FIG. 5A , FIG. 5B , FIG. 5C and FIG. 5D , or FIG. 10 and FIG. 11 .
- a self-assembled active agent may be formed by a process including covalently bonding at least a first component molecule and a second component molecule, and the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the first component molecule and the second component molecule.
- the first component molecule may be an amine and the second component molecule may be an aldehyde.
- the first component molecule may be an amine and the second component molecule may be a ketone.
- the covalent bonding between the first component molecule and the second component molecule may include the formation of a hydrazone bond.
- the first component molecule may have two or more amine functional groups.
- the first component molecule may be one of 1,3-diaminoguanidine and aminoguanidine.
- the second component molecule may have one or more aldehyde functional groups.
- the second component molecule may have three or more aldehyde functional groups.
- the second component may be one of glyoxal, glutaraldehyde, benzylaldehyde, phthalaldehyde, terephthalaldehyde, isophthalaldehyde, benzene-1,3,5-tricarboxaldehyde, 2-bromoisophthalaldehyde, 4-tBu-2,6-diformylphenol, 4-Me-2,6-diformylphenol, 3,5-diformyl-2-propoxyphenylboronic acid, 2,5-thiophenedialdehyde, and 2,5-furandialdehyde.
- a method for killing a microbe may include treating a growth of the microbe with an effective amount of a self-assembled active agent (e.g., a compound disclosed herein that has self-assembled); an effective amount of the self-assembled active agent may be achieved by adding a combination of a pre-determined amount of a first component molecule and a pre-determined amount of a second component molecule, wherein the first component molecule and the second component molecule are capable of self-assembly via the formation of a covalent bond.
- a self-assembled active agent e.g., a compound disclosed herein that has self-assembled
- an effective amount of the self-assembled active agent may be achieved by adding a combination of a pre-determined amount of a first component molecule and a pre-determined amount of a second component molecule, wherein the first component molecule and the second component molecule are capable of self-assembly via the formation of a covalent bond.
- a method of producing a self-assembled active agent may include combining a first component with a second component, wherein the first component is a molecule with an amine functional group and the second component is a molecule with an aldehyde or a ketone functional group, wherein the first component, the second component, and the combination of the first component and the second component each has a bioactivity, and wherein the bioactivity of the combination of the first component and the second component is greater than the sum of the bioactivity of the first component and the bioactivity of the second component.
- the first component and the second component may be capable of self-assembly via the formation of a covalent bond.
- the formation of a covalent bond between the first component and the second component may include the formation of a hydrazone bond.
- FIG. 1 shows exemplary reversible interactions which may be used to construct self-assembled complexes, including self-assembled active agents, as described below.
- FIG. 2 shows an exemplary scheme for the self-assembly of an active agent using a hydrazone bond through the combination of isophthalaldehyde with either aminoguanidine or 1,3-diaminoguanidine as described below.
- FIG. 3 shows IR spectra of an aldehyde alone and in combination with two different amines, demonstrating the formation of the hydrazone bond, as described below.
- FIG. 4 shows general schema for some of the self-assembled active agents described by the current invention as described below.
- FIG. 5A , FIG. 5B , FIG. 5C and FIG. 5D show structures for some particular self-assembled active agents as described below; a crisscrossed bond indicates that a double bond may be in either the cis or trans configuration.
- FIG. 7 shows the effect of pH on synergy (1/FICI) for a particular self-assembled active agent as described below.
- FIG. 8 shows a general scheme describing the formation of 2:1 (4) and 1:1 (5) adducts of mono-aldehydes or ketones with diaminoguanidine (2) or aminoguanidine (1) as described below.
- FIG. 9 shows synthesis, properties and end-of life for reversible antimicrobials based on benzaldehyde (top) compared to conventional polyguanide and quaternary ammonium (quat) antimicrobials (bottom) as described below.
- FIG. 10 shows examples of the structures of reversible antimicrobials.
- FIG. 11 shows additional examples of the structures of reversible antimicrobials.
- the word “exemplary” means “serving as an example, instance or illustration.”
- the embodiments described herein are not limiting, but rather are exemplary only. It should be understood that the described embodiment are not necessarily to be construed as preferred or advantageous over other embodiments.
- the terms “embodiments of the invention”, “embodiments” or “invention” do not require that all embodiments of the invention include the discussed feature, advantage, or mode of operation.
- compositions may be added to the composition provided they do not substantially interfere with the intended activity and efficacy of the composition; whether or not a compound interferes with activity and/or efficacy can be determined, for example, by the procedures utilized below.
- Bioactivity refers to the ability of a compound or composition to (i) prevent the growth of a pathogen or microbe, (ii) inhibit the growth of a pathogen or microbe, or (ii) substantially kill or eliminate a pathogen or microbe population.
- An active agent is a compound or composition which exhibits substantial biological activity.
- treat refers to the use of a composition to reduce or prevent a condition, symptom, or disease caused by a pathogen or microbe by (i) preventing the growth of the pathogen or microbe, (ii) inhibiting the growth of the pathogen or microbe, or (ii) substantially killing or eliminating the pathogen or microbe.
- the term “treat,” “treating,” or “treatment” may also refer to the use of a composition to kill, reduce the population of, or inhibit the growth of a pest or pest population.
- Merobe as used herein is synonymous with “microorganism” and may refer to a bacterium, fungus, algae, mold, protozoan, yeast, or other unicellular organism, or a virus.
- an effective amount of a compound or property as provided herein is meant such amount as is capable of performing the function of the compound or property for which an effective amount is expressed.
- the exact amount required will vary from process to process, depending on recognized variables such as the compounds employed and the processing conditions observed. Thus, it is not possible to specify an exact “effective amount.” However, an appropriate effective amount may be determined by one of ordinary skill in the art using only routine experimentation.
- analog or “chemical variant” of a compound refers to a structural analog of the identified compound having a similar structure and similar activity.
- Objects treated by the methods described herein include surfaces.
- Objects treated by the methods described herein also include foods and beverages.
- Foods and beverages treated by the methods described herein include meat, poultry, seafood, eggs, nuts, fruits and vegetables. Particularly included are apples, melons, apricots, peaches, pears, artichokes, beans, bell peppers, carrots, celery, tomato, lettuce, and spinach.
- Foods particularly include fresh-cut produce (e.g., fruits and vegetables) which is produce that has been, for example, peeled, cut, sliced, or shredded. The fresh-cut produce may be subsequently made into juice, or dried or dehydrated or frozen by methods known in the art.
- Objects treated by the methods described herein also include a surface, such as a kitchen countertop.
- Contacting or exposing objects with the antimicrobial composition described herein may occur by conventional methods such as spraying or dipping or immersion wherein the object is in contact with the antimicrobial solution for a certain period of time (e.g., about 120 seconds).
- compositions may be suitable in accordance with the present methods. Those working in this field would of course be readily able to determine in an empirical manner the optimum rates of application for any given combination of target microorganisms to be killed or eliminated.
- the amount of composition used will be at least an effective amount to reduce and/or kill microorganisms.
- effective microorganisms killing amount means the minimum amount of composition needed to reduce and/or kill the number of microorganisms on or in an object or area (e.g., soil, structures, plants, or agricultural commodities such as grain or wood).
- the precise amount of the composition needed will vary in accordance with the particular composition used; the type of object to be treated; the number of days of effectiveness needed; and the environment in which the object is located.
- the precise amount of the composition can easily be determined by one skilled in the art given the teaching of this application.
- Other compounds may be added to the composition provided they do not substantially interfere with the intended activity of the composition; whether or not a compound interferes with activity can be determined, for example, by the procedures described below.
- the optional carrier may be, for example, agronomically or physiologically or pharmaceutically acceptable carriers known in the art.
- the carrier component can be a liquid or a solid material.
- carrier as used herein includes carrier materials such as those described below.
- the vehicle or carrier to be used refers to a substrate such as a mineral oil, paraffin, silicon oil, water, membrane, sachets, disks, rope, vials, tubes, septa, resin, hollow fiber, microcapsule, cigarette filter, gel, natural and/or synthetic polymers, elastomers or the like. All of these substrates have been used to control and release an effective amount of a composition containing the compounds disclosed herein in general and are well known in the art.
- Suitable carriers are well-known in the art and are selected in accordance with the ultimate application of interest.
- Agronomically acceptable substances include aqueous solutions, glycols, alcohols, ketones, esters, hydrocarbons halogenated hydrocarbons, polyvinyl chloride; in addition, solid carriers such as clays, laminates, cellulosic and rubber matrices and synthetic polymer matrices, or the like.
- “Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances in which said event or circumstance occurs and instances where it does not.
- the phrase “optionally comprising a known antimicrobial” means that the composition may or may not contain a known antimicrobial and that this description includes compositions that contain and do not contain a known antimicrobial.
- the phrase “optionally adding a known antimicrobial” means that the method may or may not involve adding a known antimicrobial and that this description includes methods that involve and do not involve adding a known antimicrobial.
- compositions containing one or more (e.g., two) of the compounds described herein may contain one specific compound or may not contain that specific compound.
- a composition may contain
- composition may not contain
- inventions illustratively disclosed herein suitably may be practiced in the absence of any element (e.g., method steps or composition components) which is not specifically disclosed herein.
- the invention described herein may include any one or more of the listed active agents described herein, and in the case of the invention including a single active agent, any other active agent may be optionally excluded.
- self-assembled active agents may be produced using known processes.
- a self-assembled active agent may be the result of the assembly of two or more components.
- the self-assembled active agent may be a complex formed by the covalent bonding of two or more component molecules.
- the self-assembly may occur under a variety of conditions, depending on the desired application. According to at least some embodiments, the self-assembly occurs at room temperature in an aqueous medium.
- a controlling factor for self-assembly may be concentration of the self-assembled active agent and/or components. For example, in the case where the active agent is sufficiently diluted, the assembly may reverse, and the active agent may break apart into its separate components.
- the self-assembled active agent may be in the form of an individual molecule, consisting of as little as two components. Alternatively, the self-assembled active agent may be an oligomer or a polymer.
- the active agent may have one or more activities.
- the active agent may be an antimicrobial agent, such as an antibacterial agent.
- the active agent may also be a biocide such as an herbicide, a pesticide, or an antiviral agent. Additionally or alternatively the active agent may be a preservative, an antifouling agent, or a disinfectant.
- the active agent may be termed as having bioactivity.
- the active agent may also be a sensor agent, such as for a particular molecule or for pH.
- the bioactivity of a compound or active agent means the strength of the compound or active agent to kill, treat, reduce the number of, or inhibit growth of a microbe or other biological entity. For example, in the case of inhibition of growth of an organism, bioactivity is inversely proportional to the minimum concentration needed to inhibit the growth of the organism.
- the bioactivity of a compound or active agent also means the strength of the compound or active agent to remove a microbe or other biological entity depending on the carrier system such as a gel or encapsulating matrix; also the compound or active agent may be a cationic surfactant which can “sweep away” microbes from surfaces.
- the components of the active agent may be benign and/or biodegradable compounds.
- Exemplary components which may be used in an active agent may be amines, aldehydes, and/or ketones.
- an aldehyde is a molecule with at least one aldehyde functional group
- a ketone is a molecule with at least one ketone functional group
- an amine is a molecule with at least one amine functional group.
- the self-assembly may be achieved via dehydration synthesis.
- the active agent may thus be formed via a covalent bond, such as a hydrazone bond.
- Exemplary amines for a component in an active agent may include 1,3-diaminoguanidine and aminoguanidine.
- Exemplary aldehydes for a component in an active agent may include glyoxal, glutaraldehyde, benzylaldehyde, phthalaldehyde, terephthalaldehyde, isophthalaldehyde, benzene-1,3,5-tricarboxaldehyde, 2-bromoisophthalaldehyde, 4-tBu-2,6-diformylphenol, 4-Me-2,6-diformylphenol, 3,5-diformyl-2-propoxyphenylboronic acid, 2,5-thiophenedialdehyde, and 2,5-furandialdehyde.
- the active agent may alternatively be formed via an oxime bond, a boronic acid adduct, or any other suitable reversible bond scheme.
- exemplary reversible interactions which may be used to construct self-assembled complexes, including self-assembled active agents, are shown in FIG. 1 (adapted from DOI: 10.1002/anie.201610372 and references therein).
- FIG. 2 and FIG. 8 An exemplary scheme for the self-assembly of an active agent using a hydrazone bond is shown in FIG. 2 and FIG. 8 .
- One general procedure for preparation of the antimicrobials is by treating an aldehyde (e.g., 20 mg) or ketone (e.g., 20 mg) with aminoguanidine HCl stock solution (e.g., 180 mg; 37 wt % aminoguanidine HCl in dH 2 O) or diaminoguanidine. Reactions proceed within seconds but were typically heated for at least about 30 min at about 70° C. to ensure completion. Reactions can be typically run at about 20° to about 70° C. for about 1 minute to about 48 h; lower and higher temperatures also afford the same complexes, albeit at different rates. Typically reactions were run at neutral pH; lower and higher pH affords the same complexes at different rates and purity.
- aldehyde e.g., 20 mg
- ketone e.g., 20 mg
- aminoguanidine HCl stock solution e.g., 180 mg; 37 wt % aminoguanidine HCl in dH 2 O
- Association constants for hydrazone bonds (1:1 hydrazine to aldehyde) in water are typically 10 5 -10 7 M ⁇ 1 .
- An association constant of 10 6 M ⁇ 1 would be >99% complex as a 1 wt % solution, and dissociate ⁇ 94% to its subcomponents upon dilution of a 1 L product in a 25-meter swimming pool (375,000 Liters).
- microbial agents are active when present in their complexed state and can thus substitute for toxic, nonrenewable antiseptics, disinfectants, and preservatives that are used so prevalently in many consumer/medical products.
- these active complexes can be de-activated via dissociation, for example though changes in concentration, pH, temperature, or salt concentration.
- Aldehyde and ketone components used to produce the novel antimicrobials may be agriculturally derived (e.g., benzaldehyde, cuminaldehyde, citral from Prunus , cumin and lemongrass-based feedstocks), which could create a novel market for these green product substances.
- plant extracts, oils, flavors or fragrances can be used to produce the novel antimicrobials.
- the antimicrobial complexes themselves may find use as preservatives that would minimize food and water waste. These substances may also be used as antimicrobials, antibiotics, antiparasitics, repellents and pesticides (e.g. against insects), and herbicides and could replace current synthetic chemicals which are generally more toxic and contribute to microbial and pest resistance.
- antimicrobials could substitute for current pesticides, adjuvants/boosters, anti-biofilm actives, probiotics, disinfectants, antiseptics, antibiotics (topical and oral), and preservatives.
- antimicrobials may also be delivered through incorporation of the complex or a subcomponent in packaging.
- the antimicrobials could be used to coat or be incorporated into bottles, packaging, films, transfer lines/tubing, in process—cleaning tanks, pump surfaces etc.
- antimicrobials exhibit a limited post-use lifetime, thus minimizing opportunities for sub-inhibitory microbial exposure and resulting in development of antimicrobial resistance.
- antibiotics currently used for agriculture may be replaced by these inexpensive, non-toxic, biobased, and reversible antimicrobials.
- the product in normal use of the consumer product the product would provide maximum efficacy when the complex is together, likely, for example, when both components are at a high concentration. Thus, it is active when needed. However, after use, when efficacy is no long needed and the molecules are being washed down the drain, for example, the complex would naturally and immediately become diluted, whereby the separate molecules are benign and represent little risk to the environment. In the case of agriculture (e.g., when acting as a miticide, pest control, or food preservative), the net effect in almost all imaginable applications is that the complex would become immediately benign after use. It should be noted that the complex could be used in food or feed supplements which lose efficacy in the stomach or soon after digestion.
- Reversible antimicrobials such as those described herein, are relatively safe and benign, and thus would displace many of the current antimicrobials being banned or heavily scrutinized by regulatory agencies and consumers. In cases where current biocides are being heavily regulated, reversible analogues could completely substitute for these products by offering the novel advantage of controlled or predictable dissociation.
- Antimicrobial Agents Self-assembled active agents were created using the components shown in Table 1.
- FIG. 3 shows exemplary IR spectrographs for teraphthaldehyde only (top), and teraphthaldehyde combined with aminoguanidine or diaminoguanidine (middle and bottom, respectively).
- the concomitant disappearance of the aldehyde peak ( ⁇ 1650-1700 cm ⁇ 1 ) and appearance of the hydrazone peak ( ⁇ 1550-1650 cm ⁇ 1 ) is clear for both of the middle and bottom spectra.
- fractional inhibitory concentration indices were calculated from measured minimum inhibitory concentrations (MICs) against Pseudomonas aeruginosa and Escherichia coli .
- the MIC of each substance was determined according to standard guidelines in cation-adjusted Mueller-Hinton broth at a total volume of ⁇ 100 ⁇ l with test concentrations decreasing two-fold to span the empirically-determined MIC (J. Med. Chem., 59: 2126-2138 (2016)).
- Wells contained starting microbe concentrations of approximately 10 7 cells/mL.
- Absorbance at 600 nm (abs600) was determined immediately after inoculation using a 96 well plate reader.
- the FICI can be used to quantify the synergy between two components (X and Y). Specifically, 1/FICI can be used as a measure of synergy, interpreted as factors by which the potency of a given combination is greater than the sum of its parts (see Journal of Antimicrobial Chemotherapy, 52: 1 (2003)). For example, in the present invention, synergy may be found when the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the two or more component molecules.
- FIG. 4 General schema for some of the studied compounds are shown in FIG. 4 .
- FIG. 4 Specifically shown in FIG. 4 are general structures showing compound B combined in a complex with any of compounds 6, 8, or 11 (top left), 12 or 13 (top right), 5 (bottom left), and 1 or 2 (bottom right).
- R 1 , R 2 , R 3 , and X the represented atom(s) need not be the same within the same structure.
- the top left structure represents B+8 if R 1 is H and R 2 represents both H and Br. This simplified version is thus used for brevity.
- the specific structures formed by the combinations of each of A and B with compounds 1, 2, and 4-13 can be found in the list in FIG. 5A , for example.
- Table 2 An exemplary set of measured MICs is shown in Table 2.
- Table 2 For the data in Table 2, when multiple components were used to form a complex, the amine component was present in excess of a 1:1 molar ratio.
- the aldehydes with the strongest synergies in FIG. 5A , FIG. 5B , FIG. 5C , and FIG. 5D generally are aromatic compounds with two or more aldehyde groups. Further, though B tended to exhibit synergy with compound 5, 6, and 7, glyoxal (1) exhibited greater synergy with A than B by a small but notable margin.
- Microcystis aeruginosa was also observed in a combination of B+6 (MIC (wt %) Component B: 0.001; Component 6: 0.0001).
- the agents also have activity as against photosynthetic organisms (e.g., algae, plants) and/or as an herbicide.
- MDC Manual Dish Cleaner
- API All Purpose Cleaner
- MIC Minimum inhibitory concentrations
- Viability of microbes in formula over time The viability of microorganisms were determined by adding complexes in 0.05-1 wt % to formulations (all-purpose cleaner and manual dish) and inoculation with Aspergillus brasiliensis (ATCC 16404) to make a total cell concentration of ⁇ 1 ⁇ 10 6 spores/mL. The total volume of the mixture was 5 mL. The inoculated mixture was kept in a shaker at 30° C. for 7 days. Microorganism viability was determined by plating 100 ⁇ m of inoculated mixture on MH agar plates on days 0, 3, and 7.
- the potency of the aminoguanidine complexes against microbes were affected by the formulation that they were placed in.
- the manual dish formulation surprisingly inhibited the potency of the aminoguanidine complex against the microbes, as observed by the logarithmic reduction of one (Table 6).
- the reversible complexes are hypothesized to disrupt cellular membranes in a manner analogous to quaternary ammonium compounds (quats) and guanide based antimicrobials, such as chlorhexidine and polyhexamethyleneguanidine (Jennings, M. C., et al., ACS Infect. Dis., 1: 288-303 (2015)).
- quats quaternary ammonium compounds
- guanide based antimicrobials such as chlorhexidine and polyhexamethyleneguanidine
- reversible complexes are designed to dissociate to nontoxic, biodegradable subcomponents after use. This process is anticipated to minimize collateral toxicity and antimicrobial resistance.
- Antibiotic resistant infections kill approximately 700,000 people per year. If resistance trends continue, global annual GDP could be reduced by 2-3.5% by 2050, a loss of $60-$100 trillion of cumulative economic output. The persistence of antibiotics that linger in the environment long after their targeted use is a major cause of this problem. Antibiotics currently used for agriculture may be replaceable by inexpensive, biobased, and non-toxic reversible antimicrobials described herein.
- Table 7 surprisingly shows good to excellent performance of aminoguanidine-cuminaldehyde complex in home cleaning formulations.
- This complex was deactivated by high levels of ionic surfactants, such as in the manual dish formulation.
- Aminoguanidine adducts of more hydrophilic aldehydes i.e., 4-hydroxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, m-anisaldehyde
- Tables 8 and 9 show that the addition of aminoguanidine surprisingly increased the antimicrobial properties of complex mixtures of flavors, fragrances and bulk plant extracts and oils that are often rich sources of bioactive aldehydes. Increases in potency were typically one to two orders of magnitude. So the second component can be plant extracts, oils, flavors or fragrances.
- this class of reversible compounds will minimize the potential for collateral toxicity and antimicrobial resistance by dissociating to nontoxic subcomponents in the environment.
- covalent analogues e.g., chlorhexidine, polyhexamethyleneguanidine, quaternary ammonium compounds
- composition when it contains only one active compound does not contain the following compounds:
- This trypanocidal compound is not used by itself as a trypanocidal compound:
- This anti-malarial compound is not used by itself as an anti-malarial compound:
- This anti-protozoa and anti-bacterial compound is not used by itself as an anti-protozoa and anti-bacterial compound:
- This anti-fungal compound is not used by itself as an anti-fungal compound:
- Aminoguanidine may enhance the antimicrobial properties of plant extracts and oils ( E. coli ATCC 8739) MIC after amino- guanidine Factor addition MIC Essential increase Extract or oil wt %) Oil (wt %) in potency 1 Bergamont 1.25 greater than 2.5 2 2 Grapefruit 2.5 greater than 2.5 1 3 Orange greater than 2.5 greater than 2.5 1 4 Spearmint 1.25 greater than 2.5 2 5 Cinnamon 0.0390625 0.15625 4 6 Lavender 2.5 greater than 2.5 1 7 Patchouli greater than 2.5 greater than 2.5 1 8 Tea Tree Oil 2.5 1.25 0.5 9 Clary Sage 2.5 greater than 2.5 1 10 Lemongrass 0.15625 2.5 16 11 Lemon 1.25 greater than 2.5 2 12 Peppermint 2.5 greater than 2.5 2 13 Eucalyptus greater than 2.5 greater than 2.5 1 14 Lime 2.5 greater than 2.5 1 15 Rosemary 2.5 2.5 1 15 Vanilla 1.25 2.5 2 17 Vetiver 1.25 greater than 2.5 2 18 Bay Leaf 2.5 2.5 1 19 Cinnamon cassia 0.0390625 0.078125 2 20 Tonka Bean 2.5 1.
- Aminoguanidine may enhance the antimicrobial properties of flavors/fragrances (E. coli ATCC 9739) MIC after amino- guanidine Factor addition MIC Fragrance increase Fragrance (wt %) (wt %) in potency 1 Olive Leaf 0.625 greater than 2.5 4 2 Lime and Sea 0.625 greater than 2.5 4 3 Lemon Mint 0.0390625 1.25 32 4 Eucalyptus Mint 0.625 2.5 4 (tub/tile) 5 Eucalyptus Mint 0.3125 2.5 8 6 Clementine (Dish) 0.3125 greater than 2.5 8 7 Pink Grapefruit 0.3125 greater than 2.5 8 8 Wisteria 0.0390625 2.5 64 9 French Lavender 2.5 2.5 1 10 Lavender Cedar 0.625 2.5 4 11 Fresh Air 0.625 greater than 2.5 4 12 Waterfall 0.15625 greater than 2.5 16 13 Toasted Vanilla 1.25 2.5 2 14 Mandarin Mango 1.25 greater than 2.5 2 15 Ginger Mango 4x 2.625 2.5 4 16 Beach Sage 4x 2.5 greater than 2.5 1 17 Parsley and Thy
Abstract
Description
- This application claims priority to U.S. patent application Ser. No. 15/909,421, filed Mar. 1, 2018, which itself claims priority from Provisional Patent Application No. 62/467,324, filed on Mar. 6, 2017, the contents of both of which are incorporated herein by reference in their entireties.
- Chemical antimicrobial agents such as antibiotics, antiseptics, disinfectants and preservatives are essential for modern medicine, agriculture and other industries. Despite this importance, chemical antimicrobial agents often exhibit significant toxicity to non-microbial organisms, thereby causing collateral damage to ecosystems and also accelerating the evolution of antimicrobial resistance. The latter two problems may result from a substance's persistence in the environment. The longer a substance persists in the environment, the greater the potential for bioaccumulation and microbial exposure at sub-inhibitory concentrations, the latter of which enables the evolution of antimicrobial resistance. This effect is cause for concern; some estimates predict mortalities from antibiotic resistant infections may surpass those from cancer within several decades. Given the growing hazard of antimicrobial resistance and the damage to the environment caused by persistent chemicals, the development of antimicrobials that are short-lived in the environment is needed.
- Hydrazone bond formation has been widely used to construct thermodynamically stable, yet kinetically reversible, covalent molecular complexes that are stable in aqueous solution near neutral pH (Dirksen, et al., Nucleophilic Catalysis of Hydrazone Formation and Transimination: Implications for Dynamic Covalent Chemistry, J. Am. Chem. Soc., 128: 15602-15603 (2006); Rodriguez-Docampo, Z., and S. Otto, Orthogonal or Simultaneous Use of Disulfide and Hydrazone Exchange in Dynamic Covalent Chemistry in Aqueous Solution, Chem. Commun., pages 5301-5303 (2008)). Bond formation and dissociation is dynamic and rapid, often occurring within seconds to minutes at room temperature (King, T. P., et al., Preparation of Protein Conjugates via Intermolecular Hydrazone Linkage, Biochemistry (Mosc.), 25: 5774-5779 (1986); Dirksen, A., and P. E. Dawson, Rapid Oxime and Hydrazone Ligations with Aromatic Aldehydes for Biomolecular Labeling, Bioconjug. Chem., 19: 2543-2548 (2008); and Nguyen, R., and I. Huc, Optimizing the Reversibility of Hydrazone Formation for Dynamic Combinatorial Chemistry, Chem. Commun., pages 942-943 (2003)). These reversible bonds enable pathways for environmental degradation as they dissociate at extreme pH or upon dilution. Custalcean and coworkers employed hydrazone bond formation to construct a class of self-assembled cations that associate strongly with anions (Custelcean, R., et al., Aqueous Sulfate Separation by Crystallization of Sulfate-Water Clusters, Angew. Chem. Int. Ed., 54: 10525-10529 (2015); Custelcean, R., et al., Aqueous Sulfate Separation by Sequestration of [(SO4)2(H2O)4]4—Clusters within Highly Insoluble Imine-Linked Bis-Guanidinium Crystals, Chem.-Eur. J., 22, 1997-2003 (2016)). These complexes structurally resemble conventional polyguanidines (e.g., chlorhexidine), a class of widely used antimicrobials that are persistent and toxic.
- According to at least one aspect of the invention, a composition may include a compound of the formula:
- wherein R1 and R3 are, independently, one of a straight chain or branched, saturated or unsaturated aliphatic group, a 5-member ring, or a 6-member ring, R1 and R3 are, independently, optionally substituted one or more times, in the case of either of R1 or R3 being a 6-member ring, the 6-member ring is optionally an aromatic ring, and in the case of either of R1 or R3 having at least one substitution, a first substitution is one of an alcohol group, an aldehyde group, a 5-member ring, a 6-member ring, a halide, a halide-diol, an ether, and a straight or branched, saturated or unsaturated aliphatic group.
- According to a further aspect of the invention, the compound may be one of the compounds disclosed in
FIG. 5A ,FIG. 5B ,FIG. 5C andFIG. 5D . - According to at least one aspect of the invention, a composition may include a compound of the formula:
- wherein R1 and R2 independently represent:
(1) hydrogen (—H), or
(2) an aliphatic (saturated or unsaturated, straight chain or branched) functional group (e.g., C1-10 alkyl) that may be substituted with additional aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C1 to C10), phenolic, —OH groups, ethers (e.g. —OMe, —OEt, where the alkyl portion of the ester ranges from C1 to C10), esters (e.g. —CO2Me, —CO2Et, where the alkyl portion of the ester ranges from C1 to C10), acids (e.g. boronic, —BO2, or carboxylic, —CO2H), amines and ammoniums (e.g. —NR3R4 or —(NR3R4R5)+), alcohols (e.g. —CH2OH where the alkyl portion of the alcohol ranges from C1 to C10), thiol and thioesters (e.g. —SH, —SMe, —SEt, where the alkyl portion of the thioester ranges from C1 to C10), halogens (e.g. —Cl, —Br), and/or a 1-2 ring heterocycle that contains O, N and/or S as the heteroatom, such as morpholine, or
(3) an aromatic functional group (e.g., C6H5 or derivatives wherein one or more —H is substituted with an alkyl (e.g., C1-10), with aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C1 to C10), phenolic, —OH groups, ethers (e.g. —OMe, —OEt, where the alkyl portion of the ester ranges from C1 to C10), esters (e.g. —CO2Me, —CO2Et, where the alkyl portion of the ester ranges from C1 to C10), acids (e.g. boronic, —BO2, or carboxylic, —CO2H), amines and ammoniums (e.g. —NR3R4 or —(NR3R4R5)+), alcohols (e.g. —CH2OH where the alkyl portion of the alcohol ranges from C1 to C10), thiol and thioesters (e.g. —SH, —SMe, —SEt, where the alkyl portion of the thioester ranges from C1 to C10), halogens (e.g. —Cl, —Br), and/or a 1-2 ring heterocycle that contains O, N and/or S as the heteroatom, such as pyridine or indole;
R3, R4 and R5 independently represent a hydrogen of aliphatic (saturated or unsaturated, straight chain or branched, e.g., C1-10 alkyl) functional group that may be substituted, for example, with additional aliphatic groups (e.g. -Me, -Et, where the aliphatic portion ranges from C1 to C10), —OH groups, ethers (e.g. —OMe, —OEt, where the alkyl portion of the ester ranges from C1 to C10), esters (e.g. —CO2Me, —CO2Et, where the alkyl portion of the ester ranges from C1 to C10), acids (e.g. boronic, —BO2, or carboxylic, —CO2H), amines and ammoniums alcohols (e.g. —CH2OH where the alkyl portion of the alcohol ranges from C1 to C10), thiol and thioesters (e.g. —SH, —SMe, —SEt, where the alkyl portion of the thioester ranges from C1 to C10), or halogens (e.g. —Cl, —Br). - According to a further aspect of the invention, the compound may be an active agent.
- According to a further aspect of the invention, the active agent may be formed by self-assembly of a first component molecule and a second component molecule.
- According to yet a further aspect of the invention, the active agent may have antimicrobial activity.
- According to another aspect of the invention, a method for treating a pathogen or microbe may include applying an effective amount of an active agent to a designated area or object, the active agent being the compound described above.
- According to a further aspect of the invention, the active agent may be one of the compounds disclosed in
FIG. 5A ,FIG. 5B ,FIG. 5C andFIG. 5D , orFIG. 10 andFIG. 11 . - According to another aspect of the invention, a self-assembled active agent may be formed by a process including covalently bonding at least a first component molecule and a second component molecule, and the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the first component molecule and the second component molecule.
- According to a further aspect of the invention, the first component molecule may be an amine and the second component molecule may be an aldehyde.
- According to a further aspect of the invention, the first component molecule may be an amine and the second component molecule may be a ketone.
- According to a further aspect of the invention, the covalent bonding between the first component molecule and the second component molecule may include the formation of a hydrazone bond.
- According to a further aspect of the invention, the first component molecule may have two or more amine functional groups.
- According to a further aspect of the invention, the first component molecule may be one of 1,3-diaminoguanidine and aminoguanidine.
- According to a further aspect of the invention, the second component molecule may have one or more aldehyde functional groups.
- According to a further aspect of the invention, the second component molecule may have three or more aldehyde functional groups.
- According to a further aspect of the invention, the second component may be one of glyoxal, glutaraldehyde, benzylaldehyde, phthalaldehyde, terephthalaldehyde, isophthalaldehyde, benzene-1,3,5-tricarboxaldehyde, 2-bromoisophthalaldehyde, 4-tBu-2,6-diformylphenol, 4-Me-2,6-diformylphenol, 3,5-diformyl-2-propoxyphenylboronic acid, 2,5-thiophenedialdehyde, and 2,5-furandialdehyde.
- According to another aspect of the invention, a method for killing a microbe may include treating a growth of the microbe with an effective amount of a self-assembled active agent (e.g., a compound disclosed herein that has self-assembled); an effective amount of the self-assembled active agent may be achieved by adding a combination of a pre-determined amount of a first component molecule and a pre-determined amount of a second component molecule, wherein the first component molecule and the second component molecule are capable of self-assembly via the formation of a covalent bond.
- According to another aspect of the invention, a method of producing a self-assembled active agent may include combining a first component with a second component, wherein the first component is a molecule with an amine functional group and the second component is a molecule with an aldehyde or a ketone functional group, wherein the first component, the second component, and the combination of the first component and the second component each has a bioactivity, and wherein the bioactivity of the combination of the first component and the second component is greater than the sum of the bioactivity of the first component and the bioactivity of the second component.
- According to a further aspect of the invention, the first component and the second component may be capable of self-assembly via the formation of a covalent bond.
- According to a further aspect of the invention, the formation of a covalent bond between the first component and the second component may include the formation of a hydrazone bond.
- We have developed a new class of antimicrobials (useful against Gram-negative and Gram-positive bacteria, fungi, molds, yeasts, and viruses) based on nontoxic aldehydes and ketones (see the Figures). When treated with a potentiating agent (e.g., aminoguanidine or diaminoguanidine), a reversible covalent complex is formed that surprisingly exhibits selective or narrow- or broad-spectrum antimicrobial activity. Potencies of the resulting complexes are up to 1000 times greater than the sum of their parts. Owing to their surprisingly reversible nature, these complexes are designed to dissociate to nontoxic subcomponents after use. This degradation pathway minimizes the risks of collateral toxicity and antimicrobial resistance.
- Advantages of embodiments of the present invention will be apparent from the following detailed description of the exemplary embodiments. The following detailed description should be considered in conjunction with the accompanying figures in which:
- Exemplary
FIG. 1 shows exemplary reversible interactions which may be used to construct self-assembled complexes, including self-assembled active agents, as described below. - Exemplary
FIG. 2 shows an exemplary scheme for the self-assembly of an active agent using a hydrazone bond through the combination of isophthalaldehyde with either aminoguanidine or 1,3-diaminoguanidine as described below. - Exemplary
FIG. 3 shows IR spectra of an aldehyde alone and in combination with two different amines, demonstrating the formation of the hydrazone bond, as described below. - Exemplary
FIG. 4 shows general schema for some of the self-assembled active agents described by the current invention as described below. - Exemplary
FIG. 5A ,FIG. 5B ,FIG. 5C andFIG. 5D show structures for some particular self-assembled active agents as described below; a crisscrossed bond indicates that a double bond may be in either the cis or trans configuration. - Exemplary
FIG. 6 shows the effect of varying weight ratios of the component compounds on synergy (1/FICI) (FICI=fractional inhibitory concentration indices) for a particular self-assembled active agent as described below. - Exemplary
FIG. 7 shows the effect of pH on synergy (1/FICI) for a particular self-assembled active agent as described below. - Exemplary
FIG. 8 shows a general scheme describing the formation of 2:1 (4) and 1:1 (5) adducts of mono-aldehydes or ketones with diaminoguanidine (2) or aminoguanidine (1) as described below. - Exemplary
FIG. 9 shows synthesis, properties and end-of life for reversible antimicrobials based on benzaldehyde (top) compared to conventional polyguanide and quaternary ammonium (quat) antimicrobials (bottom) as described below. - Exemplary
FIG. 10 shows examples of the structures of reversible antimicrobials. - Exemplary
FIG. 11 shows additional examples of the structures of reversible antimicrobials. - Aspects of the invention are disclosed in the following description and related drawings directed to specific embodiments of the invention. Alternate embodiments may be devised without departing from the spirit or the scope of the invention. Additionally, well-known elements of exemplary embodiments of the invention will not be described in detail or will be omitted so as not to obscure the relevant details of the invention. Further, to facilitate an understanding of the description, discussion of several terms used herein follows.
- As used herein, the word “exemplary” means “serving as an example, instance or illustration.” The embodiments described herein are not limiting, but rather are exemplary only. It should be understood that the described embodiment are not necessarily to be construed as preferred or advantageous over other embodiments. Moreover, the terms “embodiments of the invention”, “embodiments” or “invention” do not require that all embodiments of the invention include the discussed feature, advantage, or mode of operation.
- Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. As used herein, the term “about” refers to a quantity, level, value, or amount that varies by as much as 10% to a reference quantity, level, value, or amount. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described.
- Other compounds may be added to the composition provided they do not substantially interfere with the intended activity and efficacy of the composition; whether or not a compound interferes with activity and/or efficacy can be determined, for example, by the procedures utilized below.
- The amounts, percentages, and ranges disclosed herein are not meant to be limiting, and increments between the recited amounts, percentages, and ranges are specifically envisioned as part of the invention. All ranges and parameters disclosed herein are understood to encompass any and all subranges subsumed therein, and every number between the endpoints. For example, a stated range of “1 to 10” should be considered to include any and all subranges between (and inclusive of) the minimum value of 1 and the maximum value of 10 including all integer values and decimal values; that is, all subranges beginning with a minimum value of 1 or more, (e.g., 1 to 6.1), and ending with a maximum value of 10 or less, (e.g. 2.3 to 9.4, 3 to 8, 4 to 7), and finally to each
number - “Biological activity” or, in context, “activity” refers to the ability of a compound or composition to (i) prevent the growth of a pathogen or microbe, (ii) inhibit the growth of a pathogen or microbe, or (ii) substantially kill or eliminate a pathogen or microbe population. An active agent is a compound or composition which exhibits substantial biological activity.
- The term “treat,” “treating,” or “treatment,” as used herein, refers to the use of a composition to reduce or prevent a condition, symptom, or disease caused by a pathogen or microbe by (i) preventing the growth of the pathogen or microbe, (ii) inhibiting the growth of the pathogen or microbe, or (ii) substantially killing or eliminating the pathogen or microbe. In addition, the term “treat,” “treating,” or “treatment” may also refer to the use of a composition to kill, reduce the population of, or inhibit the growth of a pest or pest population.
- “Microbe” as used herein is synonymous with “microorganism” and may refer to a bacterium, fungus, algae, mold, protozoan, yeast, or other unicellular organism, or a virus.
- The term “effective amount” of a compound or property as provided herein is meant such amount as is capable of performing the function of the compound or property for which an effective amount is expressed. As will be pointed out below, the exact amount required will vary from process to process, depending on recognized variables such as the compounds employed and the processing conditions observed. Thus, it is not possible to specify an exact “effective amount.” However, an appropriate effective amount may be determined by one of ordinary skill in the art using only routine experimentation.
- As used herein, “analog” or “chemical variant” of a compound refers to a structural analog of the identified compound having a similar structure and similar activity.
- Objects treated by the methods described herein include surfaces. Objects treated by the methods described herein also include foods and beverages. Foods and beverages treated by the methods described herein include meat, poultry, seafood, eggs, nuts, fruits and vegetables. Particularly included are apples, melons, apricots, peaches, pears, artichokes, beans, bell peppers, carrots, celery, tomato, lettuce, and spinach. Foods particularly include fresh-cut produce (e.g., fruits and vegetables) which is produce that has been, for example, peeled, cut, sliced, or shredded. The fresh-cut produce may be subsequently made into juice, or dried or dehydrated or frozen by methods known in the art. Objects treated by the methods described herein also include a surface, such as a kitchen countertop.
- Contacting or exposing objects with the antimicrobial composition described herein (to reduce and/or kill bacteria) may occur by conventional methods such as spraying or dipping or immersion wherein the object is in contact with the antimicrobial solution for a certain period of time (e.g., about 120 seconds).
- Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as molecular weight, reaction conditions (e.g., reaction time, temperature), percentages and so forth as used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless otherwise indicated, the numerical properties set forth in the following specification and claims are approximations that may vary depending on the desired properties sought to be obtained in embodiments of the present invention. As used herein, the term “about” refers to a quantity, level, value, or amount that varies by as much as 10% to a reference quantity, level, value, or amount.
- The term “consisting essentially of” excludes additional method steps or composition components that substantially interfere with the intended activity of the method or composition, and can be readily determined by those skilled in the art (for example, from a consideration of this specification or practice of the invention disclosed herein).
- All of the references cited herein, including U.S. patents and U.S. Patent Application Publications, are incorporated by reference in their entirety.
- A wide range of application rates of the compositions may be suitable in accordance with the present methods. Those working in this field would of course be readily able to determine in an empirical manner the optimum rates of application for any given combination of target microorganisms to be killed or eliminated. The amount of composition used will be at least an effective amount to reduce and/or kill microorganisms. The term “effective microorganisms killing amount” as used herein, means the minimum amount of composition needed to reduce and/or kill the number of microorganisms on or in an object or area (e.g., soil, structures, plants, or agricultural commodities such as grain or wood). Of course, the precise amount of the composition needed will vary in accordance with the particular composition used; the type of object to be treated; the number of days of effectiveness needed; and the environment in which the object is located. The precise amount of the composition can easily be determined by one skilled in the art given the teaching of this application. Other compounds may be added to the composition provided they do not substantially interfere with the intended activity of the composition; whether or not a compound interferes with activity can be determined, for example, by the procedures described below.
- The optional carrier may be, for example, agronomically or physiologically or pharmaceutically acceptable carriers known in the art. The carrier component can be a liquid or a solid material. The term “carrier” as used herein includes carrier materials such as those described below. As is known in the art, the vehicle or carrier to be used refers to a substrate such as a mineral oil, paraffin, silicon oil, water, membrane, sachets, disks, rope, vials, tubes, septa, resin, hollow fiber, microcapsule, cigarette filter, gel, natural and/or synthetic polymers, elastomers or the like. All of these substrates have been used to control and release an effective amount of a composition containing the compounds disclosed herein in general and are well known in the art. Suitable carriers are well-known in the art and are selected in accordance with the ultimate application of interest. Agronomically acceptable substances include aqueous solutions, glycols, alcohols, ketones, esters, hydrocarbons halogenated hydrocarbons, polyvinyl chloride; in addition, solid carriers such as clays, laminates, cellulosic and rubber matrices and synthetic polymer matrices, or the like.
- “Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances in which said event or circumstance occurs and instances where it does not. For example, the phrase “optionally comprising a known antimicrobial” means that the composition may or may not contain a known antimicrobial and that this description includes compositions that contain and do not contain a known antimicrobial. Also, by example, the phrase “optionally adding a known antimicrobial” means that the method may or may not involve adding a known antimicrobial and that this description includes methods that involve and do not involve adding a known antimicrobial.
- Compositions containing one or more (e.g., two) of the compounds described herein may contain one specific compound or may not contain that specific compound. For example, a composition may contain
- or the composition may not contain
- The invention illustratively disclosed herein suitably may be practiced in the absence of any element (e.g., method steps or composition components) which is not specifically disclosed herein. Further, the invention described herein may include any one or more of the listed active agents described herein, and in the case of the invention including a single active agent, any other active agent may be optionally excluded.
- According to at least one embodiment, self-assembled active agents may be produced using known processes. A self-assembled active agent may be the result of the assembly of two or more components. For example, the self-assembled active agent may be a complex formed by the covalent bonding of two or more component molecules. The self-assembly may occur under a variety of conditions, depending on the desired application. According to at least some embodiments, the self-assembly occurs at room temperature in an aqueous medium. Further, a controlling factor for self-assembly may be concentration of the self-assembled active agent and/or components. For example, in the case where the active agent is sufficiently diluted, the assembly may reverse, and the active agent may break apart into its separate components. The self-assembled active agent may be in the form of an individual molecule, consisting of as little as two components. Alternatively, the self-assembled active agent may be an oligomer or a polymer.
- The active agent may have one or more activities. For example, the active agent may be an antimicrobial agent, such as an antibacterial agent. The active agent may also be a biocide such as an herbicide, a pesticide, or an antiviral agent. Additionally or alternatively the active agent may be a preservative, an antifouling agent, or a disinfectant. In the case of the active agent being active against a microbe, bacterium, or virus, the active agent may be termed as having bioactivity. The active agent may also be a sensor agent, such as for a particular molecule or for pH.
- The bioactivity of a compound or active agent means the strength of the compound or active agent to kill, treat, reduce the number of, or inhibit growth of a microbe or other biological entity. For example, in the case of inhibition of growth of an organism, bioactivity is inversely proportional to the minimum concentration needed to inhibit the growth of the organism. The bioactivity of a compound or active agent also means the strength of the compound or active agent to remove a microbe or other biological entity depending on the carrier system such as a gel or encapsulating matrix; also the compound or active agent may be a cationic surfactant which can “sweep away” microbes from surfaces.
- The components of the active agent may be benign and/or biodegradable compounds. Exemplary components which may be used in an active agent may be amines, aldehydes, and/or ketones. For the purposes of this disclosure, an aldehyde is a molecule with at least one aldehyde functional group, a ketone is a molecule with at least one ketone functional group, and an amine is a molecule with at least one amine functional group. In the case of an amine and an aldehyde being two components to form an active agent, the self-assembly may be achieved via dehydration synthesis. The active agent may thus be formed via a covalent bond, such as a hydrazone bond. Exemplary amines for a component in an active agent may include 1,3-diaminoguanidine and aminoguanidine. Exemplary aldehydes for a component in an active agent may include glyoxal, glutaraldehyde, benzylaldehyde, phthalaldehyde, terephthalaldehyde, isophthalaldehyde, benzene-1,3,5-tricarboxaldehyde, 2-bromoisophthalaldehyde, 4-tBu-2,6-diformylphenol, 4-Me-2,6-diformylphenol, 3,5-diformyl-2-propoxyphenylboronic acid, 2,5-thiophenedialdehyde, and 2,5-furandialdehyde. The active agent may alternatively be formed via an oxime bond, a boronic acid adduct, or any other suitable reversible bond scheme. Exemplary reversible interactions which may be used to construct self-assembled complexes, including self-assembled active agents, are shown in
FIG. 1 (adapted from DOI: 10.1002/anie.201610372 and references therein). - An exemplary scheme for the self-assembly of an active agent using a hydrazone bond is shown in
FIG. 2 andFIG. 8 . - One general procedure for preparation of the antimicrobials (e.g.,
FIG. 8 ) is by treating an aldehyde (e.g., 20 mg) or ketone (e.g., 20 mg) with aminoguanidine HCl stock solution (e.g., 180 mg; 37 wt % aminoguanidine HCl in dH2O) or diaminoguanidine. Reactions proceed within seconds but were typically heated for at least about 30 min at about 70° C. to ensure completion. Reactions can be typically run at about 20° to about 70° C. for about 1 minute to about 48 h; lower and higher temperatures also afford the same complexes, albeit at different rates. Typically reactions were run at neutral pH; lower and higher pH affords the same complexes at different rates and purity. - Complexes were constructed from non-toxic aldehydes or ketones and aminoguanidine or diaminoguanidine subcomponents through a dynamic covalent hydrazone linkage (typical reaction conditions: at least about 30 minutes at about 70° C. and about neutral pH). This reversible bond dissociates on the order of seconds to hours when exposed to dilution, changes in pH, temperature, or chemical treatment (e.g., hydrazine or hydroxylamine). Hydrazone bond reversibility is well documented in the scientific literature (Nguyen, R., and I. Huc, Chem. Commun., 8: 942-943 (2003)). Association constants for hydrazone bonds (1:1 hydrazine to aldehyde) in water are typically 105-107 M−1. An association constant of 106 M−1 would be >99% complex as a 1 wt % solution, and dissociate ˜94% to its subcomponents upon dilution of a 1 L product in a 25-meter swimming pool (375,000 Liters). By providing a novel degradation pathway through dissociation, reversible antimicrobials are produced. Reversible and “controllable” antimicrobial agents are put forward as a way to limit the development of collateral antimicrobial resistance and toxicity through environmental persistence. The general advantage of these microbial agents is that they are active when present in their complexed state and can thus substitute for toxic, nonrenewable antiseptics, disinfectants, and preservatives that are used so prevalently in many consumer/medical products. However, when antimicrobial activity is no longer needed, these active complexes can be de-activated via dissociation, for example though changes in concentration, pH, temperature, or salt concentration.
- Although mechanistic investigations are ongoing, without being bound by theory these antimicrobials are envisioned to inhibit microbial growth through multiple mechanisms (e.g., membrane disruption, inhibition of oxidative phosphorylation similar to Robenidine, etc.). Minimum inhibitory concentrations for several complexes were as low as 6-70 ppm for example against resilient strains of Pseudomonas aeruginosa and Aspergillus brasiliensis. This high degree of potency is comparable to conventional, market-leading antibiotics.
- Aldehyde and ketone components used to produce the novel antimicrobials may be agriculturally derived (e.g., benzaldehyde, cuminaldehyde, citral from Prunus, cumin and lemongrass-based feedstocks), which could create a novel market for these green product substances. In addition, plant extracts, oils, flavors or fragrances can be used to produce the novel antimicrobials. The antimicrobial complexes themselves may find use as preservatives that would minimize food and water waste. These substances may also be used as antimicrobials, antibiotics, antiparasitics, repellents and pesticides (e.g. against insects), and herbicides and could replace current synthetic chemicals which are generally more toxic and contribute to microbial and pest resistance. These substances could substitute for current pesticides, adjuvants/boosters, anti-biofilm actives, probiotics, disinfectants, antiseptics, antibiotics (topical and oral), and preservatives. These antimicrobials may also be delivered through incorporation of the complex or a subcomponent in packaging. The antimicrobials could be used to coat or be incorporated into bottles, packaging, films, transfer lines/tubing, in process—cleaning tanks, pump surfaces etc.
- One big advantage of these antimicrobials is that they exhibit a limited post-use lifetime, thus minimizing opportunities for sub-inhibitory microbial exposure and resulting in development of antimicrobial resistance. Thus antibiotics currently used for agriculture may be replaced by these inexpensive, non-toxic, biobased, and reversible antimicrobials.
- To summarize the advantages of this system more directly, in normal use of the consumer product the product would provide maximum efficacy when the complex is together, likely, for example, when both components are at a high concentration. Thus, it is active when needed. However, after use, when efficacy is no long needed and the molecules are being washed down the drain, for example, the complex would naturally and immediately become diluted, whereby the separate molecules are benign and represent little risk to the environment. In the case of agriculture (e.g., when acting as a miticide, pest control, or food preservative), the net effect in almost all imaginable applications is that the complex would become immediately benign after use. It should be noted that the complex could be used in food or feed supplements which lose efficacy in the stomach or soon after digestion.
- Reversible antimicrobials, such as those described herein, are relatively safe and benign, and thus would displace many of the current antimicrobials being banned or heavily scrutinized by regulatory agencies and consumers. In cases where current biocides are being heavily regulated, reversible analogues could completely substitute for these products by offering the novel advantage of controlled or predictable dissociation.
- While this invention may be embodied in many different forms, there are described in detail herein specific preferred embodiments of the invention. The present disclosure is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated. Furthermore, the invention encompasses any possible combination of some or all of the various embodiments and characteristics described herein and/or incorporated herein. In addition the invention encompasses any possible combination that also specifically excludes any one or some of the various embodiments and characteristics described herein and/or incorporated herein.
- The following examples are intended only to further illustrate the invention and are not intended to limit the scope of the invention as defined by the claims.
- Antimicrobial Agents: Self-assembled active agents were created using the components shown in Table 1.
- The formation of complexes through a hydrazone bond was confirmed through IR spectroscopy.
FIG. 3 shows exemplary IR spectrographs for teraphthaldehyde only (top), and teraphthaldehyde combined with aminoguanidine or diaminoguanidine (middle and bottom, respectively). The concomitant disappearance of the aldehyde peak (˜1650-1700 cm−1) and appearance of the hydrazone peak (˜1550-1650 cm−1) is clear for both of the middle and bottom spectra. - To compare antimicrobial efficacy of self-assembled complexes to their components, fractional inhibitory concentration indices (FICIs) were calculated from measured minimum inhibitory concentrations (MICs) against Pseudomonas aeruginosa and Escherichia coli. The MIC of each substance was determined according to standard guidelines in cation-adjusted Mueller-Hinton broth at a total volume of ˜100 μl with test concentrations decreasing two-fold to span the empirically-determined MIC (J. Med. Chem., 59: 2126-2138 (2016)). Wells contained starting microbe concentrations of approximately 107 cells/mL. Absorbance at 600 nm (abs600) was determined immediately after inoculation using a 96 well plate reader. Plates were incubated at 37° C. and abs600 measured after 24 hours. For the purposes of these experiments, minimum inhibitory concentrations are defined as the minimum concentration observed to inhibit microbial growth over this time span, with a change in abs600 less than or equal to 0.1.
- Following MIC testing, FICI were calculated as shown in Equation 1:
-
- The FICI can be used to quantify the synergy between two components (X and Y). Specifically, 1/FICI can be used as a measure of synergy, interpreted as factors by which the potency of a given combination is greater than the sum of its parts (see Journal of Antimicrobial Chemotherapy, 52: 1 (2003)). For example, in the present invention, synergy may be found when the effective amount of the self-assembled active agent is lower than the sum of the effective amounts of the two or more component molecules.
- Neutral oxygen and sulfur-containing analogues of A and B were treated with aldehydes 1-7. Under otherwise identical conditions, these neutral analogues failed to exhibit significant synergies (1/FICI<5) (data not shown).
- MICs for combinations of A and B with aldehydes 1-13 were measured as against P. aeruginosa and E. coli. General schema for some of the studied compounds are shown in
FIG. 4 . Specifically shown inFIG. 4 are general structures showing compound B combined in a complex with any of compounds 6, 8, or 11 (top left), 12 or 13 (top right), 5 (bottom left), and 1 or 2 (bottom right). It is noted that for designations R1, R2, R3, and X, the represented atom(s) need not be the same within the same structure. For example, the top left structure represents B+8 if R1 is H and R2 represents both H and Br. This simplified version is thus used for brevity. The specific structures formed by the combinations of each of A and B withcompounds FIG. 5A , for example. - An exemplary set of measured MICs is shown in Table 2. For the data in Table 2, when multiple components were used to form a complex, the amine component was present in excess of a 1:1 molar ratio.
- The MICs determined as per above were then used to calculate FICIs. Synergism (1/FICI) was then tabulated, as shown in Table 3. Note that 1/FICI values varied with subcomponent ratio; unless otherwise noted, the values shown in Table 3 represent a molar ratio of 6:1, amine:aldehyde.
- It is noted that of the studied compounds, the aldehydes with the strongest synergies in
FIG. 5A ,FIG. 5B ,FIG. 5C , andFIG. 5D generally are aromatic compounds with two or more aldehyde groups. Further, though B tended to exhibit synergy withcompound 5, 6, and 7, glyoxal (1) exhibited greater synergy with A than B by a small but notable margin. - In addition, relative concentration of components was studied. Components A and 5 were combined in varying ratios to determine a maximum effective FICI. The conditions were that P. aeruginosa was grown in Mueller-Hinton broth under aerobic conditions and with a starting concentration of 105 cells/mL. Growth was assessed after 24 hours at 37° C. The weight ratios of A:5 were 1:1, 2:1, 4:1, 8:1, 16:1, 32:1, and 64:1. The results are shown in
FIG. 6 . As can be seen, the maximum synergy was achieved with the 8:1 weight ratio. - The effect of pH on synergy was also studied. Components B and 7 were combined in a 3:1 ratio (B:7). P. aeruginosa was grown in Mueller-Hinton broth under aerobic conditions and with a starting concentration of 105 cells/mL. Growth was assessed after 24 hours at 37° C. The results are shown in
FIG. 7 . Synergy decreased markedly as pH diverged from 7. - Other Activities: Activity against the toxin-producing blue-green algae (cyanobacteria) Microcystis aeruginosa was also observed in a combination of B+6 (MIC (wt %) Component B: 0.001; Component 6: 0.0001). Thus, the agents also have activity as against photosynthetic organisms (e.g., algae, plants) and/or as an herbicide.
- Additional Examples. Formulas: Manual Dish Cleaner (MDC) and All Purpose Cleaner (APC) obtained from UL's Prospector (www.ulprospector.com; accessed 4 PM, 9-15-17): MDC: Water 78.0%, Plantapon 611L UP (Sodium Laureth Sulfate, Lauryl Glucoside, Cocoamidopropyl Betaine, 22.0%); APC: Water 91.68%; Glucopon 420 UP (Caprylyl//Myristyl Glucoside 3.50%, Citric Acid 0.40%, NaOH 0.52%, NaHCO30.40%, Ethanol 3.50%).
- General procedure for preparation of actives: Complexes were formed by treating 20 mg of aldehyde or ketone with 180 mg of aminoguanidine HCl stock solution (37 wt % aminoguanidine HCl in dH2O) and heating at 60° C. for 48 h. The resulting product mixtures were subsequently screened for antimicrobial activity.
- Minimum inhibitory concentrations (MIC) determination: MIC were determined similarly as previously reported (Design and Testing of Safer, More Effective Preservatives for Consumer Products-ACS Sustainable Chemistry & Engineering (ACS Publications) with one exception: actives were dissolved in an all-purpose cleaner and diluted in Mueller Hinton (MH) broth. A cleaning formulation (generic All Purpose Cleaner or Manual Dish, as mentioned in “Formulas”) was used to test compatibility of actives with a representative product formulation.
- Viability of microbes in formula over time: The viability of microorganisms were determined by adding complexes in 0.05-1 wt % to formulations (all-purpose cleaner and manual dish) and inoculation with Aspergillus brasiliensis (ATCC 16404) to make a total cell concentration of ˜1×106 spores/mL. The total volume of the mixture was 5 mL. The inoculated mixture was kept in a shaker at 30° C. for 7 days. Microorganism viability was determined by plating 100 μm of inoculated mixture on MH agar plates on
days 0, 3, and 7. - Results and discussion: Following treatment with aminoguanidine, a library of 54 aldehydes were evaluated as fungal inhibitors (Table 4; conditions: spores/mL, time, temp). The most potent of these complexes were re-evaluated alongside parent aldehydes under similar experimental conditions (Table 5; conditions: spores/mL, time, temp).
- Surprisingly aminoguanidine complexes with benzaldehydes were generally more potent than their parent aldehydes. Increases in potency surprisingly ranged from one to two orders of magnitude (Table 5). The most potent of these complexes were added in formula (all-purpose cleaner and manual dish) at 0.1 wt %. A. brasiliensis cell counts were monitored and counted over seven days.
- The potency of the aminoguanidine complexes against microbes were affected by the formulation that they were placed in. The manual dish formulation surprisingly inhibited the potency of the aminoguanidine complex against the microbes, as observed by the logarithmic reduction of one (Table 6).
- Without being bound by theory, the reversible complexes are hypothesized to disrupt cellular membranes in a manner analogous to quaternary ammonium compounds (quats) and guanide based antimicrobials, such as chlorhexidine and polyhexamethyleneguanidine (Jennings, M. C., et al., ACS Infect. Dis., 1: 288-303 (2015)). In contrast to these conventional antimicrobials, reversible complexes are designed to dissociate to nontoxic, biodegradable subcomponents after use. This process is anticipated to minimize collateral toxicity and antimicrobial resistance.
- Producers are facing growing restrictions on use of biocides with poor human and environmental Producers health attributes. Reversible antimicrobials, such as those described herein, may compete with current products where consumer and environmental safety is a prominent concern. In cases where current biocides are being heavily regulated, reversible analogues could completely substitute for these products by offering the novel advantage of controlled or predictable dissociation.
- Antibiotic resistant infections kill approximately 700,000 people per year. If resistance trends continue, global annual GDP could be reduced by 2-3.5% by 2050, a loss of $60-$100 trillion of cumulative economic output. The persistence of antibiotics that linger in the environment long after their targeted use is a major cause of this problem. Antibiotics currently used for agriculture may be replaceable by inexpensive, biobased, and non-toxic reversible antimicrobials described herein.
- Table 7 surprisingly shows good to excellent performance of aminoguanidine-cuminaldehyde complex in home cleaning formulations. This complex was deactivated by high levels of ionic surfactants, such as in the manual dish formulation. Aminoguanidine adducts of more hydrophilic aldehydes (i.e., 4-hydroxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, m-anisaldehyde) circumvented deactivation in this manner and enabled effective preservation of the high surfactant manual dish formula.
- Tables 8 and 9 show that the addition of aminoguanidine surprisingly increased the antimicrobial properties of complex mixtures of flavors, fragrances and bulk plant extracts and oils that are often rich sources of bioactive aldehydes. Increases in potency were typically one to two orders of magnitude. So the second component can be plant extracts, oils, flavors or fragrances.
- Conclusions: Treatment of aldehydes and ketones with aminoguanidine or diaminoguanidine surprisingly affords complexes that exhibit antimicrobial potencies that may be orders of magnitude greater than the sum of their parts. Because complex formation is surprisingly reversible, products dissociate due to thermodynamic changes such as dilution or pH. This property appears to be general to a broad class of substrate aldehydes and ketones, surprisingly enabling the activation of nontoxic subcomponents. As in several of the aforementioned cases (e.g., cuminaldehyde, benzaldehyde, syringaldehyde, vanillin) these subcomponents may be agriculturally-derived, nontoxic and biodegradable. Compared to covalent analogues (e.g., chlorhexidine, polyhexamethyleneguanidine, quaternary ammonium compounds), this class of reversible compounds will minimize the potential for collateral toxicity and antimicrobial resistance by dissociating to nontoxic subcomponents in the environment.
- The invention illustratively disclosed herein suitably may be practiced in the absence of any element (e.g., method (or process) steps or composition components) which is not specifically disclosed herein. Thus the specification includes disclosure by silence (“Negative Limitations In Patent Claims,” AIPLA Quarterly Journal, Tom Brody, 41(1): 46-47 (2013):
-
- “ . . . Written support for a negative limitation may also be argued through the absence of the excluded element in the specification, known as disclosure by silence . . . .
- Silence in the specification may be used to establish written description support for a negative limitation. As an example, in Ex parte Lin [No. 2009-0486, at 2, 6 (B.P.A.I. May 7, 2009)] the negative limitation was added by amendment . . . . In other words, the inventor argued an example that passively complied with the requirements of the negative limitation . . . was sufficient to provide support . . . .
- This case shows that written description support for a negative limitation can be found by one or more disclosures of an embodiment that obeys what is required by the negative limitation . . . .”
- The foregoing description and accompanying figures illustrate the principles, preferred embodiments, and modes of operation of the invention. However, the invention should not be construed as being limited to the particular embodiments discussed above. Additional variations of the embodiments discussed above will be appreciated by those skilled in the art.
- Therefore, the above-described embodiments should be regarded as illustrative rather than restrictive. Accordingly, it should be appreciated that variations to those embodiments can be made by those skilled in the art without departing from the scope of the invention as defined by the following claims.
- The composition when it contains only one active compound does not contain the following compounds:
- This trypanocidal compound is not used by itself as a trypanocidal compound:
- This anti-malarial compound is not used by itself as an anti-malarial compound:
- This anti-protozoa and anti-bacterial compound is not used by itself as an anti-protozoa and anti-bacterial compound:
- This anti-fungal compound is not used by itself as an anti-fungal compound:
- Other embodiments of the invention will be apparent to those skilled in the art from a consideration of this specification or practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.
-
TABLE 1 Exemplary Components Compound Name (designation) Compound Structure Amines 1,3-diaminoguanidine (A) aminoguanidine (B) Aldehydes glyoxal (1) glutaraldehyde (2) benzylaldehyde (3) phthalaldehyde (4) terephthalaldehyde (5) isophthalaldehyde (6) benzene-1,3,5-tricarboxaldehyde (7) 2-Bromoisophthalaldehyde (8) 4-tBu-2,6-diformylphenol (9) 4-Me-2,6-diformylphenol (10) 3,5-Diformy1-2- propoxyphenylboronic acid (11) 2,5-thiophenedialdehyde (12) 2,5-furandialdehyde (13) -
TABLE 2 MICs for Lone Components and Complexes Conditions Component MIC (wt %) alone A 0.3i B >2i 1 0.04i 5 0.3i 7 0.3i A + 1 A 0.008i 1 0.001i A + 5 A 0.06i 5 0.01i A + 7 A 0.02i 7 0.003i B + 1 B 4i 1 0.7i B + 5 B 0.06i 5 0.01i B + 7 B 0.002i 7 0.0003i B + 8 B 0.004ii 8 0.0004ii B + 9 B 0.00005ii 9 0.00001ii B + 10 B 0.02ii 10 0.002ii B + 11 B 0.03ii 11 0.003ii B + 12 B 0.007ii 12 0.001ii B + 13 B 0.01ii 13 0.005ii i P. aeruginosa; ii E. coli -
TABLE 3 Synergism (1/FICI) of Several Aldehydes and Amines Component A B 1 20 0.1 2 3 <5 3 <5 <5 4 3 <5 5 20 20 6 30 200 7 20 1000* *extrapolated from eight FICI measurements where the weight ratio of B:7 varied from 1:1 to 9:1. -
TABLE 4 Minimum inhibitory concentrations (MICs) of aminoguanidine-aldehyde adducts against A. brasiliensis ATCC16404. (4 × 105 spores/mL starting spore counts) MIC Entry ALDEHYDE (R1, R2 = H for all) (wt %) 1 4-isobutylbenzaldehyde 0.0074 2 4-tert-butylbenzaldehyde 0.0298 3 4-butylbenzaldehyde 0.1190 4 4-octylbenzaldehyde 0.0149 5 2-ethoxybenzaldehyde 0.0149 6 benzaldehyde, redistilled 0.1190 7 cuminaldehyde, stock 0.0074 8 o-tolualdehyde 0.0595 9 p-tolualdehyde 0.1190 10 3-pyridinecarboxaldehyde 0.1190 11 m-tolualdehyde 0.1190 12 m-anisaldehyde 0.0595 13 cuminaldehyde, from oil 0.0149 14 cuminaldehyde, from bath 0.0298 15 veratraldehyde 0.0149 16 2,6-dimethylbenzaldehyde 0.0298 17 2-bromoisophthalaldehyde 0.0074 18 2-hydroxy-5-methyl-1,3- 0.0149 benzenedicarboxaldehyde 19 2,5-thiophenedicarboxaldehyde 0.0149 20 2,5-furandicarboxaldehyde 0.0074 21 3,4-dihydroxybenzaldehyde 0.0595 22 2,6-dimethoxybenzaldehyde 0.0149 23 2,5-dimethoxybenzaldehyde 0.0149 24 2,4-dimethoxybenzaldehyde 0.0149 25 2,4,6-trihydroxybenzaldehyde 0.0298 26 3,4,5-trimethoxybenzaldehyde 0.4762 27 2,4,5-trimethoxybenzaldehyde 0.4762 28 2,3,4-trimethoxybenzaldehyde 0.1190 29 2,4,6-trimethoxybenzaldehyde 0.0595 30 2,3-dimethoxybenzaldehyde 0.0298 31 3,5-dimethoxybenzaldehyde 0.0595 32 3,5-dihydroxybenzaldehyde 0.1190 33 2,5-dihydroxybenzaldehyde 0.1190 34 2,4-dihydroxybenzaldehyde 0.2381 35 4-hydroxybenzaldehyde 0.0298 36 4,6-dimethoxysalicylaldehyde 0.0298 37 2,3-dihydroxybenzaldehyde 0.0149 38 3-hydroxybenzaldehyde 0.0149 39 4-hydroxyl-3-methoxycinnamaldehyde 0.0298 see entry 34 40 2-hydroxyl-4-methoxybenzaldehyde 0.0149 41 3,4-dihydroxy-5-methoxybenzaldehyde 0.0595 42 3,4-dihydroxy-5-hydroxybenzaldehyde 0.0298 43 Syringaldehyde 0.0149 44 4-ethoxybenzaldehyde 0.0595 45 2,6-dimethoxy-4-hydroxybenzaldehyde 0.2381 46 1,3,5-triformylbenzene 0.4762 47 p-anisaldehyde 0.1190 48 o-anisaldehyde 0.0298 49 vanillin 0.4762 50 o-vanillin 0.0595 51 isovanillin 0.0595 52 vanillin acetate 0.2381 53 vanillin isobutyrate 0.1190 -
TABLE 5 Minimum inhibitory concentrations of aminoguanidine complexes compared to subcomponents (aldehyde, aminoguanidine or biocide standard Kathon CG) against A. brasiliensis ATCC 16404. MIC MIC (wt %) ALDEHYDE (wt %) sub- Entry (R1, R2 = H for all) Complex component 1 4-isobutylbenzaldehyde 0.0595 0.4762 4 4-octylbenzaldehyde 0.0595 0.4762 5 2-ethoxybenzaldehyde 0.0595 0.4762 7 cuminaldehyde, stock <0.0037 0.4752 15 veratraldehyde 0.0595 0.4762 17 2-bromoisophthalaldehyde <0.0037 0.0595 18 2,5-dihydroxybenzaldehyde >0.4762 >0.4762 19 2-hydroxy-5-methyl-1,3- <0.0037 0.0595 benzenedicarboxaldehyde 20 2,5-thiophenedicarboxaldehyde <0.0037 0.0595 21 2,5-furandicarboxaldehyde 0.0149 0.1190 24 2,5-dimethoxybenzaldehyde 0.1190 0.2381 25 2,4-dimethoxybenzaldehyde 0.0298 0.4762 38 2,3-dihydroxybenzaldehyde >0.4762 >0.4762 39 3-hydroxybenzaldehyde >0.4762 0.1190 41 2-hydroxyl-4- 0.0298 0.2381 methoxybenzaldehyde 44 syringaldehyde 0.1190 >0.4762 — Amino Guanidine >0.4762 — Kathon cg 0.0149 -
TABLE 6 Viability of microorganisms over seven days, measured by the logarithmic reduction in cell count of A. Brasiliensis (initial concentration = 5 × 106 cells/mL). Log Log Reduction Reduction ALDEHYDE in APC in MDC Entry (R1, R2 = H for all) formula formula 7 cuminaldehyde, stock 5 1 17 2- bromoisophthalaldehyde 2 1 19 2-hydroxy-5-methyl-1,3- 4 1 benzenedicarboxaldehyde 20 2,5- thiophenedicarboxaldehyde 2 1 21 2,5- furandicarboxaldehyde 1 1 25 2,4-dimethoxybenzaldehyde 6 1 41 2-hydroxyl-4- 1 1 methoxybenzaldehyde — Kathon cg 6 6 -
TABLE 7 Preservative Test Results of Reversible Antimicrobial in Home Cleaning Formulations Log reduction in formula Aspergillus Pseudomonas Concentration brasillensis, aeruginosa Formula Antimicrobial (wt, %) ATCC16404 ATCC9027 Shower Spray Aminoguanidine + cuminaldehyde 1 Fail* Pass Shower Spray Aminoguanidine + cuminaldehyde 0.2 Fail* Pass Window Cleaner Aminoguanidine + cuminaldehyde 0.2 Pass Pass All Purpose Aminoguanidine + cuminaldehyde 0.1 Pass Pass Cleaner Toilet Cleaner Aminoguanidine + cuminaldehyde 0.2 Pass Pass Bath Cleaner Aminoguanidine + cuminaldehyde 0.2 Fail Pass Hand soap Aminoguanidine + cuminaldehyde 0.2 Pass Pass Hand lotion Aminoguanidine + cuminaldehyde 0.5 Pass Pass Manual Dish Aminoguanidine + cuminaldehyde 1 Fail** Fail** Manual Dish Aminoguanidine + 4- 1 Pass ND hydroxybenzaldehyde Manual Dish Aminoguanidine + 2,4,6- 1 Pass ND trimethoxybenzaldehyde Manual Dish Aminoguanidine + m- anisaldehyde 1 Pass ND Manual Dish Aminoguanidine + 2,6- 1 Pass ND dimethoxybenzaldehyde Key 6 log (<1 wk) 3 log (<1 wk) fail* <3 log (2 wk) fail** -
TABLE 8 Aminoguanidine may enhance the antimicrobial properties of plant extracts and oils (E. coli ATCC 8739) MIC after amino- guanidine Factor addition MIC Essential increase Extract or oil wt %) Oil (wt %) in potency 1 Bergamont 1.25 greater than 2.5 2 2 Grapefruit 2.5 greater than 2.5 1 3 Orange greater than 2.5 greater than 2.5 1 4 Spearmint 1.25 greater than 2.5 2 5 Cinnamon 0.0390625 0.15625 4 6 Lavender 2.5 greater than 2.5 1 7 Patchouli greater than 2.5 greater than 2.5 1 8 Tea Tree Oil 2.5 1.25 0.5 9 Clary Sage 2.5 greater than 2.5 1 10 Lemongrass 0.15625 2.5 16 11 Lemon 1.25 greater than 2.5 2 12 Peppermint 2.5 greater than 2.5 2 13 Eucalyptus greater than 2.5 greater than 2.5 1 14 Lime 2.5 greater than 2.5 1 15 Rosemary 2.5 2.5 1 15 Vanilla 1.25 2.5 2 17 Vetiver 1.25 greater than 2.5 2 18 Bay Leaf 2.5 2.5 1 19 Cinnamon cassia 0.0390625 0.078125 2 20 Tonka Bean 2.5 1.25 0.5 21 Cedarwood greater than 2.5 greater than 2.5 1 22 Sandalwood 1.25 greater than 2.5 2 23 Clove 2.5 1.25 0.5 24 Oregano 0.3125 0.15625 0.5 -
TABLE 9 Aminoguanidine may enhance the antimicrobial properties of flavors/fragrances (E. coli ATCC 9739) MIC after amino- guanidine Factor addition MIC Fragrance increase Fragrance (wt %) (wt %) in potency 1 Olive Leaf 0.625 greater than 2.5 4 2 Lime and Sea 0.625 greater than 2.5 4 3 Lemon Mint 0.0390625 1.25 32 4 Eucalyptus Mint 0.625 2.5 4 (tub/tile) 5 Eucalyptus Mint 0.3125 2.5 8 6 Clementine (Dish) 0.3125 greater than 2.5 8 7 Pink Grapefruit 0.3125 greater than 2.5 8 8 Wisteria 0.0390625 2.5 64 9 French Lavender 2.5 2.5 1 10 Lavender Cedar 0.625 2.5 4 11 Fresh Air 0.625 greater than 2.5 4 12 Waterfall 0.15625 greater than 2.5 16 13 Toasted Vanilla 1.25 2.5 2 14 Mandarin Mango 1.25 greater than 2.5 2 15 Ginger Mango 4x 2.625 2.5 4 16 Beach Sage 4x 2.5 greater than 2.5 1 17 Parsley and Thyme 0.625 2.5 4 18 Mint 1.25 2.5 2 19 Almond 0.15625 2.5 16 20 Almond WF 0.073175 2.5 32
Claims (49)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/469,773 US20220015367A1 (en) | 2017-03-06 | 2021-09-08 | Self-assembled active agents |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762467324P | 2017-03-06 | 2017-03-06 | |
US15/909,421 US11166464B2 (en) | 2017-03-06 | 2018-03-01 | Self-assembled active agents |
US17/469,773 US20220015367A1 (en) | 2017-03-06 | 2021-09-08 | Self-assembled active agents |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/909,421 Division US11166464B2 (en) | 2017-03-06 | 2018-03-01 | Self-assembled active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220015367A1 true US20220015367A1 (en) | 2022-01-20 |
Family
ID=63447954
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/909,421 Active 2039-07-25 US11166464B2 (en) | 2017-03-06 | 2018-03-01 | Self-assembled active agents |
US17/469,773 Pending US20220015367A1 (en) | 2017-03-06 | 2021-09-08 | Self-assembled active agents |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/909,421 Active 2039-07-25 US11166464B2 (en) | 2017-03-06 | 2018-03-01 | Self-assembled active agents |
Country Status (3)
Country | Link |
---|---|
US (2) | US11166464B2 (en) |
EP (1) | EP3592147A4 (en) |
WO (1) | WO2018164994A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020250879A1 (en) * | 2019-04-01 | 2021-10-28 | Ospedale San Raffaele Srl | Aminoguanidine hydrazones as retromer stabilizers useful for treating neurological diseases |
US11723362B2 (en) * | 2019-09-19 | 2023-08-15 | -The United States of America, as represented by The Secretary of Agriculture | Broad-spectrum synergistic antimicrobial compositions |
CN114177137B (en) * | 2021-11-18 | 2023-04-14 | 浙江大学杭州国际科创中心 | Immunity activation based guanylated nano-drug and preparation and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE958832C (en) | 1952-11-14 | 1957-02-28 | Bayer Ag | Process for the preparation of guanylhydrazones |
GB1223491A (en) * | 1967-10-13 | 1971-02-24 | American Home Prod | Guanidines |
JPS5495638A (en) * | 1978-01-12 | 1979-07-28 | Yoshitomi Pharmaceut Ind Ltd | Antifouling agent in water |
GB201300435D0 (en) * | 2013-01-10 | 2013-02-27 | Medical Res Council | Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases |
CA3129741C (en) * | 2013-05-01 | 2023-09-19 | Neoculi Pty Ltd | Compounds and methods of treating infections |
AT516070B1 (en) * | 2014-07-31 | 2016-08-15 | Sealife Pharma Gmbh | Process for the preparation of polyguanidines |
BR112017004153B1 (en) * | 2014-09-02 | 2023-03-28 | Neoculi Pty Ltd | USE OF A THERAPEUTICLY EFFECTIVE AMOUNT OF AN ANTIPROTOZOAL COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A MEDICAL DEVICE, COMPOUND AND COMPOSITION |
US20160220510A1 (en) | 2015-02-02 | 2016-08-04 | The Board Of Regents Of The University Of Texas System | Antibiotic compounds that inhibit bacterial protein synthesis |
-
2018
- 2018-03-01 US US15/909,421 patent/US11166464B2/en active Active
- 2018-03-05 WO PCT/US2018/020858 patent/WO2018164994A1/en unknown
- 2018-03-05 EP EP18764112.1A patent/EP3592147A4/en active Pending
-
2021
- 2021-09-08 US US17/469,773 patent/US20220015367A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018164994A1 (en) | 2018-09-13 |
US11166464B2 (en) | 2021-11-09 |
US20180303100A1 (en) | 2018-10-25 |
EP3592147A1 (en) | 2020-01-15 |
EP3592147A4 (en) | 2020-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220015367A1 (en) | Self-assembled active agents | |
US4766113A (en) | Antimicrobial compositions and methods of using same | |
US4602011A (en) | Antimicrobial compositions and methods of using same | |
Paulus | Microbicides for the protection of materials: a handbook | |
RU2434382C2 (en) | Combinations of imazalil and silver compounds | |
Al‐Adham et al. | Types of microbicidal and microbistatic agents | |
ES2602481T3 (en) | Antimicrobial combinations of pyrione compounds with polyethyleneimines | |
Saniewski et al. | The biological activities of troponoids and their use in agriculture a review | |
CN101686914A (en) | Preservative-free compositions comprising cinnamic or anisic acid and a benzaldehyde (derivative) | |
Moore et al. | Types of antimicrobial agents | |
CN113795149B (en) | Various uses of nanoparticle compounds of functionalized titanium dioxide | |
KR20190102840A (en) | Eco-friendly insecticide comprising natural plant extracts and the manufacturing method thereof | |
US3595975A (en) | Disinfecting compositions | |
TR201903474A2 (en) | Multipurpose antimicrobial composition | |
CN1190533A (en) | Biocide composition for plant pathogenic microganism, preparation method and application thereof | |
MX2013008151A (en) | Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof. | |
JP2023508598A (en) | Fungicides for the prevention and control of fungal pathogens | |
ES2402041T3 (en) | Combinations of imazalil and hydroxypyridones | |
WO2010055928A1 (en) | Controlled-release antibacterial/antifungal agent for gas-phase use and antibacterial/antifungal method utilizing same | |
Rani et al. | Synergistic fungicidal efficacy of formulations of neem oil, nicotinic acid and Ferula asafoetida with α, β-unsaturated carbonyl compounds against Sclerotium rolfsii ITCC 5226 & Macrophomina phaseolina ITCC 0482 | |
MX2012014363A (en) | Combinations of pyrimethanil and monoterpenes. | |
Martin et al. | An assessment of the bactericidal and fungicidal efficacy of seventeen mineral and organic acids on bacterial and fungal food industry contaminants. | |
Fernandes et al. | Fungicidal activity of microbicides | |
US11723362B2 (en) | Broad-spectrum synergistic antimicrobial compositions | |
ES2718390B2 (en) | USE OF A FUNGICIDE COMPOSITION AS A TREATMENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, DISTRICT OF COLUMBIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HART-COOPER, WILLIAM M.;ORTS, WILLIAM J.;LYNN, LAUREN E;AND OTHERS;SIGNING DATES FROM 20210909 TO 20210922;REEL/FRAME:057569/0574 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID |